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Childhood obesity has become a serious health concern in the U.S., especially among 
Hispanic children.1 Offspring born to mothers with gestational diabetes (GDM) are more 
likely to develop obesity, type 1 diabetes (T1D), type 2 diabetes (T2D), and other metabolic 
diseases later in life.2,3 Many studies have shown that increased breastfeeding (BF) duration 
is linked to a lower prevalence of childhood overweight and obesity, diabetes, and the 
Metabolic Syndrome (MetS).4-7 In addition, early exposure to sugar sweetened beverages 
(SSBs) is linked to increased obesity in youth3. However, few studies have examined how 
infant feeding impacts growth and obesity prevalence in offspring of mothers with GDM. 
Preliminary findings from the SWIFT cohort by Gunderson et al. showed that greater BF 
intensity and duration throughout the first 12 months of life was protective against ponderal 
 vii 
growth and weight gain among children of mothers with GDM.8 To date, no study has 
examined how early life feeding in an exclusive GDM population impacts overweight and 
obesity, prediabetes, and MetS prevalence in children 1 to 19 years of age. Therefore, the 
overall goal of this analyses was to examine how early life feeding (i.e., BF duration and 
introduction to SSBs) impacts obesity, prediabetes, and MetS prevalence in offspring (1-
19 years of age) of mothers with GDM. 
The current research aims were from three different datasets all conducted in California: 
1) Using a longitudinal study with over 300 Hispanic children (8-19 y) with overweight or 
obesity, where early life feeding was collected retrospectively, the effects of BF duration 
on MetS and prediabetes in offspring from mothers with and without GDM was assessed. 
2) Using the LAC WIC 2014 survey with over 4,000 mothers with children (1-5 y), where 
early life infant feeding was collected retrospectively, the effects of exclusive BF and early 
introduction to SSBs on obesity prevalence in children born to mothers with and without 
GDM was assessed. 3) Using an ongoing prospective cohort of 1,035 postpartum women 
diagnosed with GDM during pregnancy, where the association of BF duration and intensity 
and early introduction to SSBs and fruit juice during the first year of life with subsequent 
overweight and obesity in children (2-5 y) was assessed. 
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Chapter 1:  Introduction and Review of Literature 
HISPANICS -A HIGH-RISK POPULATION 
As of 2017, there were 58.9 million people of Hispanic origin or 18.1% of the total 
population living in the United States (U.S.), making up the largest ethnic minority group.9 
Hispanics are one of the fastest growing ethnic minorities in the U.S. and they are estimated 
to make up 28% of the nation by 2060.9 California has the nation’s largest Hispanic 
population (15 million) among states and Hispanics comprise 39% of the state population 
with about 98% being of Mexican origin.10 According to the World Health Organization 
(WHO), in 2014, over 41 million children under the age of five were either obese or 
overweight worldwide.11 In the U.S., Hispanics are disproportionately affected by obesity, 
with around 40% of Hispanic youths (2-19 years of age), being overweight or obese (Body 
Mass Index (BMI) for Age ≥85th Percentile of the CDC Growth Charts), compared to 
28.5% non-Hispanic white (NHW) youths. Approximately 9.4% of Hispanic infants (birth 
to 2 years of age) were obese with a BMI z score of ≥95th percentile of CDC growth chart, 
compared to 6.6% NHW babies in 2012.12 Moreover, Hispanic young children (2-5 years 
of age) had a higher rate (30%) of overweight or obesity, compared to NHWs.13 
Hispanic youth have increased risk of obesity related metabolic disease, such as 
Type 2 Diabetes (T2D) and cardiovascular disease.14-17 Goran et al. previously showed that 
over 30% of Hispanic children (8-19 years of age) have prediabetes and the metabolic 
syndrome (MetS).16,18 Compared to NHWs, Hispanics have elevated levels of visceral 
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adiposity, are insulin resistant, and exhibit early signs of β-cell dysfunction, all of which 
are linked to increased risk of T2D and cardiovascular disease.19-21 The prevalence of T2D 
is 1.9 times higher in Hispanics compared to NHWs.22 Hispanic pregnant women are 
affected by gestational diabetes mellitus (GDM) more than NHW mothers. The prevalence 
estimate of GDM in Asian/Pacific Islanders (16.3%) and Hispanics (12.1%) was higher 
than NHW pregnant women (6.8%) in 2010.23 In addition, the likelihood of mortality from 
T2D in Hispanics is 50% more than NHWs.24 While Hispanic women have the highest 
rates of BF initiation25, they are more likely (33%) to provide formula supplementation as 
early as two days postpartum compared to other racial/ethnic groups in the U.S.26 
Compared with NHW mothers, Hispanic and African American mothers have lower rates 
of exclusive BF (EBF) and are more likely to introduce solid foods and sugar sweetened 
beverages (SSBs) before four months of age.27 
GESTATIONAL DIABETES MELLITUS 
GDM is one of the most common complications of pregnancy in women 
worldwide. American Diabetes Association (ADA) defines GDM as “any degree of 
glucose intolerance with onset or first recognition during pregnancy”.28 The International 
Association of Diabetes and Pregnancy Groups (IADPSG) recommends diagnosis of GDM 
based on having at least one abnormal value including fasting plasma glucose (FPG) ≥92 
mg/dl, one-hour plasma glucose concentration ≥180 mg/dl, and two-hour plasma glucose 
concentration ≥153 mg/dl after a 75-gram oral glucose tolerance test (OGTT) in pregnant 
women.29,30 Twenty five percent of pregnancies in Asia and 5% of U.K. pregnancies are 
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affected by GDM.31 While the true prevalence of GDM is unknown, depending on the 
population, approximately 1-14% of pregnant women are diagnosed with GDM annually 
in the U.S.23,32,33 According to the Centers for Disease Prevention and Control (CDC), the 
average GDM prevalence rate among fifteen U.S. states was 9.2% in 2010.23 Moreover, 
women of ethnic/racial minority groups in the U.S., especially Hispanic and Asian 
American subgroups, have consistently higher prevalence and risk of GDM, compared to 
NHW women.32,34-41 
COMPLICATIONS OF GDM IN MOTHERS 
GDM has been related to several short- and long-term complications for women 
diagnosed with GDM during pregnancy and their offspring.42 Some of the main risk factors 
of GDM include early menarche43,44, low pre-pregnancy levels of sex hormone-binding 
globulin (SHBG)45, obesity and higher than normal BMI, T2D, history of macrosomia 
(birth weight >4 kg), weight gain between pregnancies, caesarian section, and multi-
parity.46-50 Untreated GDM throughout pregnancy is associated with higher rates of 
maternal morbidity.51-54 Even mild hyperglycemia during pregnancy can adversely 
influence maternal health and is associated with a significantly higher risk of metabolic 
and hypertensive disorders later in life.55 Research shows that women with GDM during 
pregnancy are more likely to have higher calorie intake, gain weight44,56, and develop Non-
Alcoholic Fatty Liver Disease (NAFLD)57 following pregnancy compared to women 
without GDM. Though blood glucose level returns to normal in most women with GDM 
after delivery, they are still seven times more likely to develop T2D over their lifetime 
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compared to women without GDM. 47,48,50,58-60 Many studies suggest that women with 
GDM, especially those who were obese prior to pregnancy, are at considerably higher risk 
of cardiovascular disease, compared to non-GDM women.42,61-64 Oza-Frank and 
Gunderson reported that women diagnosed with GDM during pregnancy were less likely 
to breastfeed in the first hour postpartum and in the hospital65, and more likely to have 
delayed onset of lactation >3 days postpartum.66,67 
COMPLICATIONS OF GDM IN OFFSPRING 
Children born to mothers with GDM are at high risk of perinatal morbidity and 
mortality and long-term complications.51,68-70 A cohort of 796,346 French women, 57,629 
of whom were mothers with GDM, found a 30% increase in the odds ratio (OR) for 
perinatal death in the GDM group compared to the non-GDM group.71 Bone fracture, 
shoulder dystocia, born large for gestational age (LGA), and macrosomia are some of the 
severe perinatal consequences of in utero exposure to GDM.3,31,70,72,73 Offspring born to 
mothers with GDM are also at increased lifelong risks for metabolic and cardiovascular 
diseases74 and are more likely to develop impaired glucose tolerance and T2D, increased 
adiposity and obesity, and GDM (in female offspring) later in life.51,68-70 A recent study of 
970 mother-child dyads in China showed that offspring of mothers diagnosed with GDM 
had higher rates of abnormal glucose tolerance, overweight or obesity, and lower β-cell 
function compared to offspring of mothers without GDM, independent of pre-pregnancy 
weight, childhood obesity, or being born LGA.75 Two studies on Chinese mothers and their 
offspring found that maternal GDM increased the cardiometabolic risk in early childhood 
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(7-10 years of age), but not at 15 years of age.76,77 Similarly, a prospective, population-
based birth cohort on 5,038 subjects in the U.K. found no clear association between 
maternal GDM and offspring cardiometabolic risk at a mean age of 15.5 years.78  
There has been inconsistency in reports on the influence of GDM on childhood 
metabolic disease risk, particularly T2D, in different racial and ethnic groups, with some 
studies showing an association between intrauterine exposure to hyperglycemia in GDM 
offspring with impaired insulin sensitivity and secretion in adulthood68,79,80 while others 
found no effect. Numerous studies have reported that offspring exposed to intrauterine 
GDM were at significant risk of developing MetS in childhood. A U.S. based study of 94 
children of GDM mothers and 85 children of mothers without GDM (control) who were 
either large for gestational age (LGA; n= 84) or appropriate for gestational age (AGA; n= 
95) and were evaluated at six, seven, nine, and 11 years, reported that LGA offspring born 
to mothers with GDM had about five times higher risk of MetS (≥3 components) at age 11 
than non-GDM groups.81 
It is well established that GDM throughout pregnancy is a contributing factor to 
childhood obesity.82-86 A recent multinational cross-sectional study of 4,740 children 
reported a significant association between maternal GDM and increased odds of obesity 
and central obesity in children (9–11 years of age) in twelve countries including U.S.; 
however, these associations were not completely independent of maternal weight.72 A 
study of 33,893 mothers and their offspring (birth-7 years of age) in the U.S. found that the 
odds of childhood obesity were 1.45-fold higher for children born to mothers with GDM 
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versus without GDM.87 Similarly, a retrospective study of 7,355 children (mean age of 5.8 
years) born to mothers with GDM in Germany, found that the odds of childhood 
overweight (OR 1.81) and obesity (OR 2.80) were higher for offspring of mothers with 
GDM, compared to the non-GDM group.88 The Northwestern University Diabetes in 
Pregnancy Study reported a dramatic increase in weight of children born to mothers with 
GDM after five years of age, and weight for age BMI >90th percentile by age eight in over 
50% of the offspring of GDM mothers.89  A prospective cohort study of 280,866 Swedish 
children born to mothers with GDM examined the impact of GDM on BMI in early 
adulthood and found that GDM was associated with greater mean BMI (average of 0.9 
kg/m2) in male offspring at age 18, compared to their brothers born prior to their mothers’ 
GDM diagnoses.90 Likewise, early findings of the longitudinal Pima Indian Study showed 
that the offspring of Pima Indian women with GDM had 40% higher rates of obesity at age 
5–29 years than the offspring of women without GDM.91 
The mechanisms by which the risk of obesity in offspring increases by intrauterine 
exposure to diabetes are not fully understood. Exposure to maternal diabetes is associated 
with excess fetal growth in utero, possibly due to fetal hormonal alterations and 
perturbations in fetal fat accretion. In a prospective longitudinal study, Logan et al. used 
MRI and spectroscopy to determine adipose tissue quantity and distribution and 
intrahepatocellular lipid (IHCL) content of 86 infants over the first 12 postnatal weeks and 
found that GDM offspring who were exclusively breastfed had significantly greater total 
adipose tissue volume and IHCL at 10 weeks than infants of non-GDM women.92 Dabelea 
et al. found that exposure to maternal GDM in utero results in elevated leptin synthesis, 
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hyperglycemia, and hyperinsulinemia in offspring. Moreover, maternal prenatal GDM may 
also influence and alter the expression of genes that direct the accumulation of body fat or 
related metabolism in a fetus.93 
While there are numerous studies showing the impact of GDM on overweight or 
obesity prevalence in the offspring later in life, there are a few that failed to find a clear 
association between maternal GDM and obesity in offspring.77,78,82,83,94 For example, Pettitt 
et al. found no significant relationship between maternal diabetes during pregnancy and 
BMI z-scores of children (two years of age) in the U.K.; however, this study included 
subjects with T2D and Type 1 Diabetes (T1D) and timing of maternal diabetes (before 
birth or after birth) and maternal age of diabetes diagnosis were adjusted as covariates.94-96 
The majority of the previous studies were conducted on non- Hispanic children <12 months 
or >5 years of age; therefore, the current study evaluated MetS, prediabetes, and childhood 
obesity prevalence in GDM offspring with a wide age range of children (1-19 years of age). 
BREASTFEEDING 
Breast milk has been regarded as the best food for infants to meet their daily 
nutrients and energy requirements.97 The World Health Organization (WHO) defines BF 
in three different classifications including EBF (feeding infants exclusively with breast 
milk and no other liquids or solids), predominant (full) BF (receiving almost all the 
nutrients from breast milk but consumes some other liquids), and any BF (feeding with 
some breast milk during a day).98 American Academy of Pediatrics and WHO both 
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recommend initiation and continuation of EBF within one hour and for the first six months 
after birth, respectively.98-100 
BF saves the lives of more than 800,000 children under the age of five years 
annually; however, most infants and children do not receive optimal feeding. For instance, 
only about 43% of infants (0-6 months of age) are exclusively breastfed worldwide98. 
According to the current CDC state wide BF report card101, approximately 52% and 25% 
of infants in the U.S. were exclusively breastfed at 3- and 6-months of age in 2014-2015, 
respectively. Data from CDC describes that about 30% of mothers in southern U.S. states 
and 19% of mothers in western U.S. states completely stopped BF and/or pumping breast 
milk before one month postpartum.102 The state of California had the highest rate (93%) of 
women who ever breastfed their infants in 2014. California had also longer rates of BF 
duration, with 56% and 25% of mothers exclusively breastfeeding for 3- and 6-months 
postpartum, respectively. However, according to the most recent reports from the Maternal 
and Infant Health Assessment (MIHA) survey in California, Hispanic and Asian/pacific 
islander minority groups had the lowest rates of EBF at 3- and 6-months after delivery, 
compared to Black and NHW groups in 2013-2014.103 In the current study, we will 
examine how early life infant feeding (BF duration, introduction to SSBs/solids) affects 
childhood overweight and obesity prevalence in California. 
Similarly, several researchers have shown that women with GDM are less likely to 
exclusively breastfeed in the first hour postpartum and more likely to formula feed their 
children in the hospital than women without GDM.65-67,104-106 In the SWIFT cohort of 
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women with GDM, insulin treatment during pregnancy was associated with delayed onset 
of lactogenesis.67 Likewise, findings of the PRAM study that involved 72,755 women from 
30 U.S. states and New York City showed that GDM women had lower BF initiation and 
continuation compared with non-GDM women.106 In a cohort of 883 women diagnosed 
with GDM during pregnancy, Gunderson et al. found that women with GDM had shorter 
and less EBF (i.e., less lactation intensity) at 6-weeks post-delivery.107 In addition, 
Nommsen-Rivers et al. found GDM to increase the likelihood of low milk supply (i.e., 
maternal nipple problems or difficulties with latching).105 This study will assess how BF 
duration impacts childhood growth and obesity prevalence in offspring born to mothers 
with GDM.  
BREASTFEEDING HEALTH BENEFITS FOR LACTATING MOTHERS 
BF provides many health benefits for lactating mothers. Research shows that BF 
accelerates weight loss in lactating mothers and has protective effects against maternal 
obesity postpartum.60,107-111 Widen et al. found that mothers who breastfed exclusively for 
longer duration gained less weight postpartum, compared to those who BF for shorter 
duration; however, they found no association between BF and body composition in 
lactating mothers.112 In addition, several studies show that BF (any duration) significantly 
reduces rate of premenopausal breast cancer, ovarian cancer, obesity, T1D, T2D, and 
cardiovascular diseases and metabolic disease in mothers who breastfeed their infants, later 
in life.2,113-117  
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A prospective cohort study by Stuebe et al.  found a strong association between 
longer total and exclusive BF duration and higher ghrelin and pancreatic Protein peptide 
YY (PYY) levels in lactating mothers at three years postpartum.118 PYY is known for its 
role in metabolism and appetite regulation (i.e., appetite suppression) and its low levels is 
linked to obesity. Although high ghrelin stimulates hunger in the fasting state, PYY levels 
rise and ghrelin levels drop after feeding. In contrast, research shows that lower levels of 
ghrelin increase the risk for obesity, insulin resistance, hypertension, and T2D in the 
mother.118-120 Finding of studies on health benefits of BF to both lactating GDM and non-
GDM mothers are similar. Numerous studies by Gunderson et al. have consistently 
reported that higher lactation intensity is associated with decreased risk of T2D in the 
mother and improvements in maternal glucose tolerance, lipid profiles, and metabolic risk 
factor profiles during the postpartum period among women diagnosed with GDM 
throughout pregnancy.49,60,107-109,121 
BREASTFEEDING AND OBESITY IN OFFSPRING 
While BF has been shown to have numerous benefits to the lactating mothers, it 
has many long-term health benefits to the child. Children and young adults who were 
breastfed as babies are 20-50% less likely to become overweight or obese.97,122-126 Table 1 
displays studies that have assessed the impact of BF on childhood obesity in offspring of 
both GDM and non-GDM mothers. Numerous studies have shown that lower BF duration 
and intensity increases the likelihood of overweight and obesity in children.127-130 A cohort 
of 4,680 infants in the U.K. found that BF for longer than four months was independently 
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associated with 6.8% lower growth velocity in children compared to those who were 
breastfed <4 months.131 Likewise, a study of 915 mother-child dyads in the U.S. showed a 
significant association between exclusive BF for at least four months and smaller rate of 
increase in weight-for-length percentile of offspring at one year of age, compared to those 
who were BF <4 months or used formula, independent of maternal BMI.132  
Similar studies reported that infants of mothers who did not receive breast milk 
grew faster from birth to six months of age than those whose mothers initiated BF, and 
those who breastfed ≥2 months133 and ≥4 months.131,134 Moreover, findings of the Western 
Australian Pregnancy Cohort Study indicated that cessation of exclusive BF <4 months 
was linked to significant increases in weight z-scores between birth and one year of age, 
early rapid growth at age three, and probability of exceeding the 95th percentile of weight 
from 1-8 years of age. Longer exclusive BF duration (>6 months) was also associated with 
significantly lower prevalence of overweight and obesity at 20 years of age.135 Although 
there is increasing evidence that BF has a protective effect against obesity in offspring, the 
majority of these studies did not target exclusive GDM population and most just controlled 
for GDM status in their analyses. 
The SWIFT cohort by Gunderson et al. showed that greater BF intensity and 
duration throughout the first 12 months of life is protective against ponderal growth and 
weight gain among children of mothers with GDM.136 Another study of 382 mothers and 
their offspring (2-5 years of age) from the SWIFT Offspring Study in the U.S. by The 
SWIFT Offspring Investigators showed that higher BF intensity and duration was 
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associated with lower odds of obesity in offspring exposed to GDM in utero.137 A 
retrospective study of 2,295 children (2-4 years of age) of Hispanic mothers with GDM 
during pregnancy showed that offspring who were breastfed ≥12 months had a 72% 
decrease in obesity prevalence.124 In a study of 324 GDM mothers and their children (2-8 
years of age) in Germany, found that BF exclusively for at least three months reduced 
overweight prevalence by 40-50% in early childhood, after controlling for parental obesity 
and high birth weight.85  
In contrast, a prospective cohort of 1,152 Asian women with GDM (n=181) in 
Singapore reported that offspring of mothers without GDM who were breastfed ≥4 months 
had slower growth rate from birth to 36 months of age than those who were not breastfed 
or BF <4 months; however, they did not find similar results in offspring of mothers with 
GDM. In the GDM offspring, greater breast milk intake was associated with accelerated 
weight gain and BMI in the first six months of age. Of note, this study did not examine 
factors such as adverse newborn health outcomes and early prematurity that may confound 
infant feeding and early growth velocity. Additionally, this study did not differentiate 
exclusive and predominant (full) BF groups, which might explain their conflicting 
findings.138 Similarly, a study of 112 infants (birth-2 years of age) born to mothers with 
GDM showed a significant association between exclusive BF (any duration) and increased 
childhood relative body weight and blood glucose at two years of age; however, after 
adjustment for the volume of breast milk consumed during the first week of life, all these 
associations were eliminated.139 Pettitt et al. found no significant association between 
maternal diabetes during pregnancy and BMI z-score of children at two years of age; 
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however, type of diabetes was adjusted as a covariate in their analysis and their findings 
were not exclusively on GDM.94-96 The above conflicting studies highlight the need to 
further investigate the role that BF plays in obesity levels in GDM offspring. Thus, the 
current study will evaluate how BF impacts obesity prevalence and changes in adiposity in 
children born to mothers with GDM. 
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Table 1. Breastfeeding and Obesity in Offspring  
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- maternal age 
- maternal education 
- maternal BMI at 
26-28 weeks-
gestation 






- With diabetes 
mellitus  
BF≥4 months ~ 
accelerated 
•  weight gain 
• growth velocity 
 










Multi U.S. GDM vs. 
Non-
GDM 
- Never BF 
- ≥6 mos. 
- sex 







- EGWG and GDM  
Children of 
mothers with:  
- known type 1 
diabetes  





BF≥6 months ~ 
decreased 
•  risk of childhood 
overweight 
at age 2 years 
Crume et 
al.140 




Multi U.S. GDM vs. 
Non-
GDM 
- <6 mos. 




- current diet 
- physical activity 
levels 
Unknown BF≥6 breastmilk 
months ~ reduced 
• weight gain  
• overall body size  
• BMI growth velocity  
Ø Similar result for 
GDM & non-GDM 
Crume et 
al.141 




Multi U.S. GDM vs. 
Non-
GDM 
- <6 mos. 




- Tanner stage 
- age × Tanner 
interaction 
Unknown BF≥6 breastmilk 
months ~ lower 
• BMI 
• waist circumference 
• SAT level 
• VAT level 
Ø Similar result for 
GDM & non-GDM 
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Table 1. Breastfeeding and Obesity in Offspring  











2007 retrospective 8-13 
yrs. 







- ≥12 mos. 
- age 
- sex 
- body composition 
- GDM  





known to affect 
body 
composition 
- had syndromes 
or diseases 




- had had any 
major illness at 
any time 
- BF (any duration) no 
significant protective 
effects on:  
•  Adiposity (total fat 
mass, total lean 
tissue mass, percent 
body fat, VAT, SAT) 
• T2D risk (fasting 
glucose, 2-h glucose, 
insulin dynamics (SI, 
AIR, and DI)) 




2019 prospective 2-5 
yr. 
382 Multi U.S. GDM vs. 
Non-
GDM 
- <3 mos. 
- ≥3 mos. 
- 12 mos. 
combined 
- race/ethnicity 
- gestational age at 
birth 
- maternal age 
- parity 
- education  
- pre-pregnancy 
BMI 
- total gestational 
weight gain (kg) 
- GDM treatment  
- gestational age at 
GDM diagnosis 
- weight-for-
length z score 
infant diet 
- had serious 
medical 
conditions (e.g., 











- Lower intensity and 
shorter duration of BF 
~  
• Elevated  infant 
soothability and 
activity temperament 




Table 1. Breastfeeding and Obesity in Offspring  











2010 retrospective  1-15 
yrs. 
125 multi Canada Pre-GDM 
T2D 
(n=44) 
 + T1D 
(n=81) 





total BF  
- age 
- race/ethnicity 
- diabetes duration 
& type 
- parity 
- BF frequency  
- BF duration 
- maternal & child 
weight and height 
- had no 
documented 
evidence of 




- BF >3.5 mos.~ 
decreased 






2018 prospective 2-5 
yr. 



















- gestational age at 
birth 
- maternal age 
- parity 
- education  
- pre-pregnancy 
BMI 
- total gestational 
weight gain (kg) 
- GDM treatment 
type 
- gestational age at 
GDM diagnosis 
- had serious 
medical 
conditions (e.g., 











- Higher intensity and 
longer duration of BF 
~  
• slower increases in 
ponderal growth 
• more favorable 
growth patterns 
• lower weight gain 




2019 longitudinal 4-6 
yrs. 






- Any BF<5 
mos. 
- maternal age 
- maternal ethnicity 







- delivery mode 
- household income 
- SGA at birth 





Higher duration of BF~  
• lower risk of being 
overweight/obese at 
4-6 years of age. 
- No association between 
BF, and obesity in 
offspring born to 




2002 prospective 2 
yrs. 






(DBM) vs.  
- age 
- sex 
- birth weight 
- gestational age 
- Women with 
diabetes  
- DBM volume 
0.14 0.16 
Higher volume of DBM 
ingested ~ higher 
• relative body weight  
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Table 1. Breastfeeding and Obesity in Offspring  

















- type of maternal 
diabetes 
- maternal BMI 
- BBM volume 
 
 
• risk of overweight at 
2 yrs. of age 
Higher volume of BBM 
ingested ~lower 
• body weight at 
follow-up  




2005 prospective 0-2 
yrs. 








- Not BF 
- Solely BF 




- birth weight 
- gestational age 
- type of maternal 
diabetes 
- maternal BMI 
- maternal age 
model II 
- maternal blood 
glucose 
model III 
- DBM volume 
ingested 
model IV 
- BF duration  
- Unknown Exclusive BF ~ 
increased 
• risk of overweight  
• 120-min blood 
glucose  
model II: no 
relationship between 
GDM and the outcome 
 
Ø Neither late neonatal 
DBM intake nor the 
duration of BF had an 
independent influence 
on childhood risk of 
overweight or IGT  




2014 retrospective 2-4 
yrs. 
2,295 Hispanic U.S. GDM vs. 
Non-
GDM 
- No BF  
- ≥1  to <6 
mos. 
- 6 to <12 
mos. 
- ≥12 mos. 
- race/ethnicity 
- sex 
- birth weight 
- child’s age in 
months 
- maternal BMI 
- women with 





- BF >12 months in the 
GDM group 
- any duration of BF in 
the non-GDM 
mothers ~ 
• reduce obesity levels 
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Table 1. Breastfeeding and Obesity in Offspring  











 et al.85 
2006 retrospective 2-8 
yrs. 
324 German Germany GDM vs. 
Non-
GDM 
- Never BF 
- 1-3 mos. 
- >3 mos. 
- parental obesity 
- high birth 
- Unknown - BF >3 months ~ 40-
50% childhood 
overweight  
- Never BF~ higher 
childhood overweight  
Bell et 
al.147 
2018 prospective 2-3 
yrs. 
953 Australian Australia n/a - < 17 wks.  
- 17 -25 wks. 
- 26-51 wks.  
- ≥52 wks. 
- maternal age  
- level of education 




- delivery method 
- infant sex and 
birth weight  
- intending to 
relocate within the 
next 12 months 
• BF≥12 mos.~ 
• lower risk of 
being 
overweight/obese 




2012 retrospective 2-4 
yrs. 
1,438 Hispanic U.S. n/a - No BF 
- 1 wk. to <6 
mos. 
- 6 to <12 
mos. 
- ≥12 mos. 
- mother’s BMI 
- child’s sex and 
age 
- type of milk 
most often 
consumed 
- Unknown - >12 months of BF 
duration  




2014 cross-sectional 2-4 
yrs. 
2,295 Hispanic U.S. n/a - No BF 
- 1 wk. to <6 
mos. 
- 6 to <12 
mos. 




- mother’s BMI 
- GDM status 
- birth weight 
- ≤24 mos. 
- prematurity 
- LBW 
- >12 months of BF 
duration  
~ prevent obesity  
Forbes 
et al.148 
2018 prospective 0-12 
mos. 
1,087 Canadian Canada n/a - EBF 
- Partial BF 
- No BF 
- FF 
- <3 mos. 
- ≥3 mos. 
- <6 mos. 
- race/ethnicity 
- infant sex 
- birth weight 
- maternal pre-
pregnancy BMI 
- delivery mode 
- Parity 
- Unknown - Longer BF 
duration (partial 
and exclusive) 




Table 1. Breastfeeding and Obesity in Offspring  









- ≥6 mos. - GDM 
- smoking status 
- education 
~Higher risk of 





2009 prospective 0-1 
yr. 
154 Danish Denmark 
Iceland 
n/a - 0–2 mos. 
- 3–4 mos. 
- ≥5 mos. 
- birth weight 
- country 





- EBF ≤2 mos. ~ 




2014 prospective  1.5-
8 
yrs. 
41,572 Asian Japan n/a - 1-2 mos. 
- 3-5 mos. 
- ≥6 mos. 
- birth weight 
- sibling 
- maternal age 
- education 
- smoking status 
- education 
- income 




gestational age  
- BF missing data  
- BF (any duration) 






et al. 131 
2014 longitudinal  4-12 
mos. 
4680 British U.K. n/a - No BF 
- birth - 1 wk. 
- 1 wk. - 1 mo. 
- >1–2 mos. 
- >2–3 mos. 
- >3–4 mos. 
- <4 mos. 
- ≥4 mos. 
- age 
- sex 
- gestational age 
- maternal BMI 
- parity 




- Unknown - Longer BF (>4 
months vs never) 
~lower growth 
velocity 
- Later weaning (≥6 
mos. vs <4 mos.) ~ 
lower 
- Growth velocity 
- Smaller size 
Martin et 
al.150 




Belarus n/a - <3 mos. 
- 3-6 mos. 
- ≥6 mos. 
- n/a - No BF intention   
- illnesses that 
contraindicate 
BF  
- preterm  
- LBW 
- Apgar score <5  
- BF duration not 
~obesity and IGF-1 
Metzger 
et al.151 
2010 longitudinal 0-19 
yrs. 
976 Multi U.S. n/a - BF vs not-
BF 
- child's own 
lifestyle-related 
behaviors 
- parental BMI 




Table 1. Breastfeeding and Obesity in Offspring  















9 yrs. 7,798 Irish Ireland n/a - Never BF 
- ≤4 wks. 
- 5-8 wks. 
- 9-12 wks. 
- 13-25 wks. 




- child's own 
lifestyle-related 
behaviors 
- parental BMI 
- Unknown - Longer BF ~ lower  








764 Brazilian Brazil n/a BF: 
- 0 
- <3 mos. 
- 3-5 mos. 
- 6-11 mos. 
- ≥12 mos. 
EBF: 
- 0 
- <1 mo. 
- 1-3 mos. 
- 4-6 mos. 
- sex 
- age 
- birth weight 
- gestational age 
- order of birth 
- siblings 
- type of school 
- physical activity  
- television time  
-  diet 
- education 
- pregnancy 
weight gain  
- smoking  
- with persistently 
high levels of 
systolic/diastolic 
BP 
- suspected for 
secondary 
hypertension  
- Duration of BF 
was not ~ lower  




2018 prospective 6 yrs. 315 Spanish Spain n/a - EBF 
- Any BF 
- FF 
- sex 
- birth weight 
- weight gain in 
first year of life 
- maternal age 
- pregestational 
maternal BMI 
- alcohol intake  
- smoking 
- nationality  
- education  
- family income 
- employment  
- newborns 
admitted to the 
neonatal unit 
during the first 
48 hours 
- a linguistic 
barrier  
- Delayed FF~ lower  




2009 longitudinal 0-6 yrs. 7,643 
 










- LBW - Infants fully-
breastfed≥4mos.  
• gain less weight 
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Table 1. Breastfeeding and Obesity in Offspring  
















2,066 Australian Australia n/a - 0 
- <2 mos. 
- 2 to <4 mos. 
- 4 to <6 mos. 
- ≥6 mos. 
- sex 
- age 
- birth weight 
- gestational age 
- education 















n/a - BF in 
hospital 
- ≤3 mos. 





- <6 months of 
age 
- with any serious 
health condition 
that could alter 
normal feeding 
practices 
 BF practices was not 
~ with 
• weight status 
























- Unknown - EBF ≥6 mos. ~ 
lower 


















- pre/full term 
- Unknown - EBF to 3 months 








3 yrs. 884 Multi U.S. n/a - Never 
- any BF <6 
mos. 
- partial BF ≥6 
mos. 
- EBF ≥6 mos. 
- sex 
- age 
- birth weight 
- race/ethnicity 
- education 
- smoking  
- maternal BMI 
- pregnancy 
weight gain 
- gestational age 
at birth was <34 
weeks 
- EBF ≥6 mos. ~ 
lower 
• BMI z score 
• skinfold 
thicknesses 
• odds of obesity at 
age 3 years  
- Infant weight 
changes 0-6 mos. 
mediate 
associations of BF 
with BMI 
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BREASTFEEDING AND METABOLIC DISEASE IN OFFSPRING 
The inverse association between BF and incident of T2D and metabolic disease has 
been found in numerous cohorts of lactating women and their offspring. Table 2 highlights 
studies that have assessed the impact of BF on metabolic disease risk. BF (any duration) 
has been linked to lower risk of T1D, T2D, cardiovascular disease, and metabolic disease 
in both mothers and children later in life.2,113-116 A recent systematic review by Binns et al. 
found that BF protects against the development of T1D in young adolescents and T2D in 
adults.110 A study in the offspring of Pima Indian mothers found an association between 
exclusive BF and decreased risk for T2D in children and adolescents (10-39 years of age), 
after adjusting for maternal GDM.160 Numerous literature reviews by Gunderson et al. 
reveal that research on the association between BF and lower risk of T2D is very limited 
in the offspring of mothers with GDM.8,161-164 
To date, the only prospective study that assessed protective effects of BF on T2D 
in the GDM offspring used data from the cohort of Pima Indians and found that offspring 
of mothers with GDM (n=21) who were exclusively BF had lower prevalence of T2D, 
compared to those who were not breastfed or were bottle fed throughout their infancy; 
though, their results were not statistically significant.160 While many of the studies 
mentioned in Table 2 controlled for GDM or type of maternal diabetes during pregnancy, 
few examined the interaction of BF and GDM on glucose/insulin action in children. 
Therefore, the current study will examine the effect of BF on metabolic parameters in 
offspring with and without exposure to GDM population
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Table 2. Breastfeeding and Metabolic Disease in Offspring 








2007 Retrospective 8-13 
yrs. 












- GDM  




- with diabetes 
- taking medications 
known to affect 
body composition 
- had syndromes or 
diseases known to 
affect body 
composition or fat 
distribution 
- had any major 
illness at any time.  










AIR, and DI)) 









704 European Sweden; 
Estonia 
n/a - No BF 
- >1 mo. 
- 1 to <3 mos. 
- 3 to <6 mos. 




- pubertal status 
-  BMI/ fat 
mass/fat-free 
mass  
- taking medications 
that might influence 
the results 
- Exclusive BF≥6 
months ~ with  
• less low- grade 
inflammation 









1,996 European Sweden; 
Estonia 
- n/a - <3 mos. 
- 3–6 mos. 





- pubertal status 
- BMI/ fat 
mass/fat-free 
mass  
- taking medications 
that might influence 
the results  
- had 
contraindications to 










• lower CVD risk 







167 Multi U.S. Any DM - Ever BF vs. 








- child BMI z-
score 
- multiple births 
- gestational age<38 
weeks 
- missing perinatal 
information 
 
- BF is protective 
against  
• development of 
T2D in youth,  
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Table 2. Breastfeeding and Metabolic Disease in Offspring 












U.S. n/a - EBF ≥2 mos. 
- EFF ≥2 mos. 








- maternal diabetes 
during pregnancy 
- Exclusive BF≥2 
months~ 
• lower risk of 
T2D later in life 
Pettitt et 
al.166 









- EBF ≥2 mos. 
- EFF ≥2 mos. 









- unknown - EBF≥2 months~ 
• lower risk of 















milk (BBM)  
- age 
- sex 
- birth weight 
- gestational age 
- type of maternal 
diabetes 
- maternal BMI 
- maternal diabetes  - Higher volume 
of DBM ~ 
• Reduced T2D 
risk 
• Increased 





2005 Prospective 0-2 
yrs. 








- Not BF 
- Solely BF 




- birth weight 
- gestational age 
- type of maternal 
diabetes 
- maternal BMI 
- maternal age 
model II 
- maternal blood 
glucose 
model III 
-  DBM volume 
ingested 
model IV 
- BF duration  
- offspring of women 
without diabetes 
during pregnancy 
(type 1 diabetes and 
GDM) 
 
- EBF ~ increased 
120-min blood 
glucose  
model III:  
no association 
model II:  
no relationship 
between maternal 
blood glucose and 
the outcome 
- Neither late 
neonatal DBM 
intake nor BF  
duration had an 
independent 
influence on 
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- ≥24 mos. 
 
- birth weight 
- child z height 
-  child age 
- child sex 





- family income 
- household smok
e exposure 






- Chronic conditions 
except asthma, 
severe development
al delay, failure to 
thrive, gestational 
age of < 32 weeks 






















- type of maternal 
diabetes 
- None - BF>12 months~ 
• Decreased risk 










EARLY INTRODUCTION TO SOLIDS IN GDM OFFSPRING 
Breast milk and formula will meet the nutritional requirements of infants up to age 
6-months. After 6-months of age, solid foods are recommended to provide enough energy 
and adequate vitamins and iron.169 The American Academy of Pediatrics (AAP) 
recommends initiation of solid and complementary foods no earlier than 4 months of 
age.170 Early introduction to solids (<4 months of age) is associated with early exposure to 
pathogens and increased risk of developing obesity171, T1D, and celiac disease.172,173 On 
the other hand, delaying start of complementary foods until significantly later than six 
months of age may result in inadequate energy intake, iron deficiency, disinterest in solid 
foods, and consequently decelerated growth in children.174 In a longitudinal cohort of 847 
children (birth-3 years of age), the timing of solid food introduction to infants who were 
not breastfed or BF <4 months was associated with almost a six-fold increase in odds of 
obesity at three years of age.175 
In addition, research shows that mothers who BF ≥4 months are less likely to 
introduce solids early.173 A cohort of 2,907 infants reported that early introduction to solid 
foods was a risk factor for earlier cessation of BF, increased consumption of fatty or sugary 
foods, SSBs, and consequently obesity at one year of age.169 Other studies also consistently 
shows that early intake of energy and macronutrients (i.e., fat, protein, carbohydrates) from 
nutrients other than breast milk or formula in early childhood (minimum of two years old) 
are linked to increased adiposity and childhood obesity.176-178 Table 3 includes studies that 
have assessed the influence of early introduction to solids on childhood obesity.  
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Although there is increasing evidence that early introduction to solids is associated 
with faster growth rate (increase weight and BMI changes) and higher prevalence of 
obesity in children, few studies have examined this in offspring born to mothers with GDM. 
In addition, the majority of studies examining the impact of BF on obesity or subsequent 
metabolic disease have not assessed the timing of introduction to solids or the type of solids 
concurrently. This study will examine the effects of BF and early introduction to SSBs and 
fruit juice, on obesity and metabolic parameters in predominantly Hispanic offspring, both 











Table 3. Early Introduction to Solids in Offspring 






















1,181 NHW U.S. n/a - <4 mos. 
- ≥4 mos. 
- <4 mos. 
- 4–<6 mos. 
- ≥6 mos. 





- birth weight 
- gestational age 
- maternal diabetes 
type 
- maternal BMI 
- education  
- income  
- pre-pregnancy 
BMI 
- marital status 
- parity  
- beverage intake 









- Introduction to 
solids <4 ~ 
• obesity 
- Timing of 
introduction of 
solids was not ~ 





2018 prospective 2-3 
yrs. 
953 Australian Australia n/a - <17 wks.  
- 17-25 wks. 
- 26-51 wks.  
- ≥52 wks. 
- <17 wks.  
- 17 -25 wks. 
- ≥26 wks.  
- maternal age  





- maternal smoking 
- delivery method 
- infant sex 






• BF≥12 mos.~ 
- lower risk of 
overweight/obesity 
than those BF< 17 
wks. 
- Early introduction 







2009 prospective 0-3 
yrs. 
10,533 British U.K. n/a - No BF 
- <4 mos. 
- ≥4 mos. 
- <4 mos. 







- smoking  













- Longer BF ~ less 
weight gain 
- Early introduction 
of solids was not 
associated with 
faster weight gain 
 29 
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2008 prospective 0-1 
yr. 
2,907 Multi U.S. n/a - BF in 
hospital 
- <6 mos. 
- >6 mos. 
 
- Solids: 




- education  
- income  
- parity  
- region 
- no EBF 
through 16 
wks. for the 
following 
reasons  
Early intro to 



















U.K. n/a - Never 
- <4 mos. 
- ≥4mos. 



















solids <4mos.  ~ 
Weight gain 
 











847 Multi U.S. n/a - <4 mos. 
- ≥4mos. 
- <4 mos. 















solids <4mos. ~ 
• weight gain x6 
• increase in BMI 
z scores at 3 yrs. 
(in FF not BF 
infants) 
if the infant was 
breastfed, this was 
protective against 
the effects of 
introducing solids at 










116 Mexican Mexico n/a - <3 mos. 
- ≥3 mos. 
- <6 mos. 
- ≥6 mos. 
- unknown - unknown Introduction to 
solids <6 mos. & 
BF<3 mos. ~ 
• obesity 
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Table 3. Early Introduction to Solids in Offspring 


















438 Multi U.S. n/a - <6 mos. 
- <12 mos. 
- <4 mos. 
- 4 to <6 
mos. 
- ≥6 mos. 
- maternal 
race/ethnicity 
- WIC receipt 
- maternal 
smoking 





- gestational age 












Longer BF~ with 
slower  
- growth 
Age at solids 
introduction was not 





2013 longitudinal 2-4 
yrs. 
14,150 Multi U.S. n/a - BF vs not-
BF 
- <4 mos. 
- 4-5 mos. 
- ≥6 mos. 
- age 
- race/ethnicity 
- education  
- income 
- birth weight 




- died prior 
to their first 
birthday 







Longer BF and 
delay in intro to 
solids~ lower 

















n/a - BF in 
hospital 
- ≤3 mos. 
- ≤6 mos. 
- any - age 
- sex 
- race/ethnicity 
- education  
- infants<6 
mos. 











BF practices or 
timing of 
introduction of 
beverages and solid 
foods were not ~ 
with 
• weight status 
BF (any) ~ later 
introduction to SSBs 
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Table 3. Early Introduction to Solids in Offspring 
















2015 prospective 0-6 
yrs. 
43,848 Asian China n/a - Never vs. 
ever 
- ≤3 mos. 
- 4-6 mos. 
- >6 mos. 
- age  
- sex 
- birth weight 
- gestational age 
- delivery mode 
- weight gain 
during first 3 
mos.  
- BF status 
- maternal age at 
birth 
- maternal BMI  








kg or <1.5 
kg) 




or < 5)  
- Introduction to 
solids <3 mos. ~ 
with greater 
• BMI z-score 
• higher risk of 
overweight 
(11%) 







EARLY INTRODUCTION TO SSBS IN GDM OFFSPRING 
Mounting evidence points to sugar consumption in particular sugar-sweetened 
beverages (SSBs), as a key modifiable factor contributing to obesity and related metabolic 
disorders.126-130,126,184-188 The Study of Latino Adolescents at Risk for Diabetes (SOLAR) 
cohort has consistently shown that high SSB intake is significantly related to adiposity and 
T2D risk factors in Hispanic adolescents (8-19 years of age).189,190 Davis et al. found that 
the combination of BF ≥12 months and limited exposure to SSB intake was linked to a 
65% reduction in obesity prevalence in 2,300 primarily Hispanic children (2-4 years of 
age) participating in Women, Infant, and Children (WIC) clinics in Los Angeles, CA.191 In 
another separate cohort of 1,483 primarily Hispanic children (2-4 years of age) 
participating in WIC, children who were not breastfed and consumed ≥2 SSB per day, had 
60% higher obesity rate compared to children breastfed for ≥12 months and had no SSB 
intake.126  
Similarly, in a longitudinal study of low-income African American children (3–5 
years of age), SSB intake was positively associated with 10-20% increase in the prevalence 
of obesity after two years.192 Table 4 includes studies that have examined the impact of 
early introduction to solids/beverages on childhood obesity. While some of the mentioned 
studies examined obesity prevalence in offspring of GDM, they did not examine the impact 
of early SSB intake on adiposity changes in Hispanic children (1 to 19 years of age) born 
to mothers with GDM. It is important to examine if and how GDM status impacts the effect 
of infant feeding on obesity prevalence in the offspring. 
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2016 longitudinal 8-14 
yrs. 
227 Hispanic Mexico n/a - ≤12 mos. 
- >12 mos. 
- SSBs 
- ≤12 mos. 
- >12 mos. 
- sex 
- any BF up to 
age 12 months 
- maternal obesity 
- concurrent age 
- non-SSB-
energy intake 
- physical activity 
- TV time 
- unknown SSB ≤12 mos. 
~ increased  












1,438 Hispanic U.S. n/a - No BF 
- 1 wk. -<6 
mos. 
- 6 -<12 
mos. 
- ≥12 mos. 
- No SSB 
- Mid SSB 
- High SSB 
- mother’s BMI 
- child’s sex and 
age 





- preterm  
- age <2 and 
>4y  
>12 months of 
BF duration 
and low SSB 








2,295 Hispanic U.S. n/a - No BF 
- 1 wk. to 
<6 mos. 
- 6 to <12 
mos. 
- ≥12 mos. 
- No SSB 
- Mid SSB 




- mother’s BMI 
- GDM status 
- birth weight 
- preterm  
- ≤24 mos. 
- LBW 
>12 months of 
BF duration 
and no SSB 
intake ~ 
prevent obesity  
Faith et 
al.137 
2019 prospective 2-5 
yr. 




- <3 mos. 
- ≥3 mos. 
- 12 mos. 
combined 
- ≤6 mos. 
- >6 mos. 
- race/ethnicity 
- gestational age  
- maternal age 
- parity 
- education  
- pre-pregnancy 
BMI 
- total gestational 
weight gain (kg) 
- GDM treatment  
- gestational age at 
GDM diagnosis 
- weight-for-
length z score at 
birth 
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2008 prospective 0-1 
yr. 
2,907 Multi U.S. n/a - BF in 
hospital 
- <6 mos. 
- >6 mos. 
 
- <10 mos. 
- >10 mos. 
- age 
- race/ethnicity 
- education  
- income  
- parity  
- region 
- unknown Early intro to 
solids<4 mos. ~  





2019 prospective 2-5 
yr. 




- 0-3 mos. 
- ≥3mos. 
 
- <6 mos. 
- ≥6 mos. 
- race/ethnicity 
- gestational age 
at birth 
- maternal age 
- parity 
- education  
- pre-pregnancy 
BMI 
- total gestational 
weight gain (kg) 






















Compared to other minority groups in the U.S., the pathway to obesity occurs much 
earlier in life among Hispanics, suggesting that early life feeding practices may be more 
critical for the health of Hispanic children.193 Hispanic offspring born to mothers with 
GDM are more likely to develop obesity and T2D later in life. To date, little research has 
been conducted to assess how infant feeding (BF duration and introduction to SSBs) affects 
growth rate (weight and BMI changes) during the first year of life and adiposity changes 
and metabolic disease risk between 1-19 years of age in Hispanic offspring born to mothers 
diagnosed with GDM during pregnancy. Therefore, the overall goal of this study is to 
examine how early life infant feeding (BF duration and introduction to SSBs) impacts 
growth, obesity prevalence, and risk for subsequent metabolic diseases in Hispanic 
offspring exposed to GDM in utero.  
For the first analysis (chapter 2), data from a longitudinal study with over 300 
Hispanic youth (8–19 years of age) with an average of four annual inpatient and outpatient 
visits was used. Data on family history of diabetes, GDM of mothers, child’s birth weight, 
BF duration were collected retrospectively at baseline and data on prediabetes and MetS 
were collected at each annual visit. The aim of this study (Aim 1) was to assess the 
associations of BF and GDM with the prevalence of MetS and prediabetes in Hispanic 
youth as they age (8-19 years). The hypothesis of Aim 1 was that BF for at least one month 
would be  associated with lower odds of MetS and prediabetes in offspring born to mothers 
with and without GDM. For the second analysis (chapter 3), we used data from a cross-
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sectional study with over 4,000 mothers with children (1-5 years of age) participating in 
the WIC program in Los Angeles County, CA. Height and weight were measured on all 
children at their WIC clinic visits while GDM occurrence and early life feeding (EBF 
duration) were collected retrospectively and current SSBs intake of children was collected 
cross-sectionally via a survey. This study aimed (Aim 2) to examine the individual and 
interaction effects of exposure to GDM , EBF during the first year of life, and current SSB 
intake at 1-5 years of age on obesity and overweight prevalence. We hypothesized that 
EBF for at least six months and low SSB intake at 1-5 years of age would be associated 
with lower odds of overweight and obesity in children of mothers with and without GDM. 
For the third analysis (chapter 4), a prospective, observational cohort study followed 1,035 
GDM mothers and their offspring from Kaiser Permanente Northern California (KPNC) 
hospital from 2008 to 2011. BF intensity and duration, and SSBs and 100% fruit juice 
exposure were collected during the first year of life and anthropometry data were retrieved 
from KPNC medical records. The third analysis aim (Aim 3)  was to determine how early 
life modifiable factors (i.e., BF duration and intensity, and introduction to SSBs and 100% 
fruit juice during the first year of life) impact subsequent obesity prevalence in children 
aged 2-5 years who were exposed to maternal GDM. For this analysis we hypothesized 
that lower BF duration and intensity and early introduction to SSBs  and 100% fruit juice 
(during the first year of life) would be associated with higher prevalence of overweight and 
obesity in children (2-5 years of age) of mothers with GDM. 
 37 
Chapter 2: Association of Breastfeeding and Gestational Diabetes 
Mellitus with the Prevalence of Prediabetes and the Metabolic 
Syndrome in Offspring of Hispanic Mothers 
Vandyousefi S, Goran MI, Gunderson EP, et al. Association of breastfeeding and 
gestational diabetes mellitus with the prevalence of prediabetes and the metabolic 
syndrome in offspring of hispanic mothers. Pediatric Obesity. 2019;14(7):e12515.1 
 
ABSTRACT 
The effects of breastfeeding (BF) on Metabolic Syndrome (MetS) and diabetes mellitus in 
children exposed to Gestational Diabetes Mellitus (GDM) in utero have rarely been 
evaluated. This study assessed BF and GDM in relation to the prevalence of prediabetes 
and MetS in Hispanic children and adolescents (8-19y). This is a longitudinal study with 
229 Hispanic children (8-13y) with overweight/obesity, family history of diabetes, and an 
average of four annual visits (AV). Participants were categorized as: Never (negative for 
prediabetes/MetS at all AVs); ever (positive for prediabetes/MetS at any visit); intermittent 
(positive for prediabetes/MetS at 1-2 AVs); and persistent (positive for prediabetes/MetS 
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at ≥3 AVs). Compared to GDM offspring who were not BF (referent), GDM offspring who 
were BF had lower odds of persistent prediabetes (OR=0.18, 95%CI:0.04-0.82, p=0.02) 
and MetS (OR=0.10, 95%CI:0.02-0.55, p=0.008). Compared to referent group, non-GDM 
offspring who were BF, and non-GDM offspring not BF had lower odds of persistent 
prediabetes (OR=0.10, 95%CI:0.03-0.39, p=0.001; OR=0.05, 95%CI:0.01-0.11, p<0.001) 
and MetS (OR=0.14, 95%CI:0.04-0.59, p=0.01; OR=0.04, 95%CI:0.01-0.11, p<0.001). 
These results show BF is protective against prediabetes and MetS in offspring regardless 











Prediabetes is a condition defined as having higher than normal levels of fasting 
plasma glucose (FPG), oral glucose tolerance test (OGTT) 2 hour blood glucose,  glycated 
hemoglobin (HbA1c), or a combination of these, but not high enough to be diagnosed as 
type 2 diabetes194. In the United States (U.S.), the prevalence of prediabetes among 
adolescent population (12-19 years of age) ranges from 15 to 47% 195. Early onset of 
prediabetes during childhood increases risk of type 2 diabetes , the metabolic syndrome 
(MetS)196, and cardiovascular disease later in life. According to the SEARCH for Diabetes 
in Youth study, the prevalence of type 2 diabetes among adolescents younger than 20 years 
of age, 50% of whom being Hispanics, is estimated to increase four-fold over the next 30 
years197.  
The Metabolic Syndrome (MetS) is a condition described as having at least three 
of the following cardiometabolic risk factors: abdominal obesity, hypertriglyceridemia, 
hyperglycemia, hypertension, and low high-density lipoprotein (HDL) cholesterol198. Over 
30% of U.S. adults had MetS in 2012199. Approximately 5% of adolescents and 30% of 
children who had obesity were diagnosed with MetS in 2010200. Hispanics have the highest 
prevalence of MetS compared to other racial/ethnic groups in the U.S.201. In addition, 
Hispanic youth have increased risk of obesity-related metabolic diseases, such as type 2 
diabetes and cardiovascular disease202,203. Goran et al. previously showed that over 30% of 
Hispanic children and adolescents (8-19 years of age) have prediabetes and MetS16,18.  
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Gestational Diabetes Mellitus (GDM), defined as “any degree of glucose 
intolerance with onset or first recognition during pregnancy”, is one of the most common 
metabolic complications of pregnancy worldwide28. According to the International 
Diabetes Federation (IDF), GDM impacted one in seven births in 2017204. In the U.S., the 
prevalence of women with GDM was 7.6% between 2007 and 2014205. Children born to 
mothers with GDM are more likely to develop prediabetes, MetS, and increased adiposity 
later in life206,207. A longitudinal cohort of 6-11 year old children showed that GDM 
offspring who were large for gestational age (LGA) had 3-5 times higher prevalence of 
MetS than non-GDM children born appropriate for gestational age81. Another study of 168 
Danish offspring born to mothers with GDM found that GDM offspring had a six-fold 
increased risk of prediabetes (17%) compared to non-GDM offspring (3%)208. Women of 
ethnic minority groups in the U.S., especially Hispanics, have consistently higher 
prevalence and risk of GDM, compared to non-Hispanic white (NHW) women34,39,40. 
Hispanics (9.3%) and Mexican Americans (9.9%) had higher prevalence of GDM 
compared to NHWs (7.0%) in the U.S between 2007-2014205.		 
Breast milk has been regarded as the best food for infants to meet their daily 
nutrients and energy requirements. Breastfeeding (BF) saves the lives of more than 800,000 
children under the age of five years annually; however, most infants and children do not 
receive optimal feeding98. The American Academy of Pediatrics and the World Health 
Organization (WHO) both recommend initiation and continuation of exclusive BF (feeding 
infants exclusively with breast milk and no other liquids or solids) within one hour and six 
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months after birth, respectively98,99. According to the current Centers for Disease Control 
and Prevention (CDC) BF Report Card101, approximately 52% and 25% of infants in the 
U.S. were exclusively breastfed at 3- and 6-months of age in 2014-2015, respectively. Data 
from CDC shows that approximately 30% of mothers in southern U.S. states and 19% of 
mothers in western U.S. states completely stopped BF and/or pumping breast milk in 
2014102. Compared with NHW mothers, Hispanic and African American mothers have 
lower rates of exclusive BF27.  
A few studies have shown that women with GDM throughout pregnancy compared 
to those without GDM are less likely to exclusively breastfeed in the first hour postpartum, 
are more likely to formula feed their children, and have delayed onset of lactation mainly 
due to diabetes, insulin treatment, and obesity67,209. Numerous retrospective studies have 
reported the inverse association between BF history (any duration) and risk factors 
associated with MetS such as hyperglycemia, high blood pressure, obesity, cardiovascular 
disease, type 2 diabetes, and metabolic diseases in both mothers and children later in life2. 
However, research on the association between BF and lower risk of diabetes and MetS is 
limited in offspring of mothers with GDM162. In addition, research suggests that BF may 
decrease the prevalence of MetS, although not all findings are consistent210,211.  
To date, no study has examined the association between BF and GDM status on 
prevalence of MetS and prediabetes in young children, particularly in a high-risk Hispanic 
population. Therefore, this study aims to assess the effects of BF and GDM on the 
prevalence of MetS and prediabetes in Hispanic children and adolescents as they age (8-
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19 years). This study hypothesized that a history of BF for at least one month will be 
associated with decreased MetS and prediabetes risk in older children of mothers reporting 
previous GDM or no GDM. 
METHODS 
The design, data collection procedures, and findings of the University of Southern 
California longitudinal SOLAR (Study of Latino Adolescents at Risk for Diabetes) cohort 
have been previously described in detail212. The present analyses included 229 children 
(enrolled at ages 8-13 years), with an average of four annual inpatient and outpatient visits 
(range of 2-7 visits). According to IDF, “MetS should not be diagnosed in children younger 
than 10 years”213; therefore, 198 children (10-19 years of age) who had complete MetS 
parameters for at least three annual visits were evaluated for persistence of MetS. Data was 
collected between 2004-2013. Participants were recruited from Los Angeles County, CA 
and met the following inclusion criteria: 1) age 8 to 13 years at baseline, 2) family history 
of type 2 diabetes in at least one parent, grandparent, or sibling determined by parental self-
report, 3) Hispanic origin (all four grandparents of Hispanic origin as determined by 
parental self-report), and 4) body mass index (BMI) ≥85th percentile for age and sex based 
on CDC growth charts214.  
Participants taking any medications known to affect fat distribution, body 
composition, insulin action, or insulin secretion and those diagnosed with diseases that may 
influence insulin action and secretion such as lipoatrophic diabetes and cystic fibrosis, or 
body composition and fat distribution such as Cushing and Down syndromes were 
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excluded from the study. SOLAR was approved by the Institutional Review Board of the 
University of Southern California. Informed written consent and assent were obtained from 
both parents and children, respectively, before testing commenced. 
Anthropometrics and Adiposity Measures 
A licensed pediatric health-care provider performed a detailed physical exam where 
Tanner staging was determined using established guidelines215,216. Height, weight and 
waist circumference (at the umbilicus) were measured to the nearest 0.1 cm, 0.1 kg and 0.1 
cm, respectively. Blood pressure was taken in the sitting position and measures were 
repeated rapidly in triplicate at each annual visit18. BMI and BMI z-scores were determined 
by using the EPII 2000 software (version 1.1; CDC, Atlanta, GA, USA). Total body fat 
and soft lean tissue were measured by dual-energy X-ray absorptiometry (DXA) with the 
use of a Hologic QDR 4500W (Hologic, Bedford, MA, USA).  
Oral Glucose Tolerance Test 
After an overnight fast, a 2-hour OGTT was administered with a dose of 1.75 g 
glucose/kg body weight (to a maximum of 75 g). Blood samples were assayed for glucose 
and insulin after five minutes (fasting state), and two hours (relative to glucose ingestion).  
Assays 
Glucose from the OGTT was analyzed on a Dimension Clinical Chemistry system 
using an in vitro hexokinase method (Dade Behring, Deerfield, IL). Glucose was assayed 
 44 
in duplicate on a Yellow Springs Instrument 2700 Analyzer (Yellow Springs Instrument; 
Yellow Springs, OH) using the glucose oxidase method. Fasting blood samples were also 
measured for triglycerides, and total and HDL cholesterol using the Vitros chemistry DT 
slides (Johnson and Johnson Clinical Diagnostics Inc., Rochester, NY). 
GDM and BF Measures 
Data on family history of diabetes, maternal GDM status, child’s birth weight, BF 
initiation and duration were assessed at baseline via parental self-administered 
questionnaires. In the current study, BF duration was analyzed as categorical variables (i.e., 
“No BF Group” who were breastfed 0 or < 1 month vs. “BF Group” who were breastfed ≥ 
1 month). Children were divided into four categories based on GDM and BF: 1) mothers 
without GDM and were breastfed (i.e.; “non-GDM, BF”), 2) mothers without GDM and 
were not breastfed (i.e.; “non-GDM, no-BF”), 3) mothers with GDM and were breastfed 
(i.e.; “GDM, BF”), and 4) mothers without GDM and were not breastfed (i.e.; “GDM, no-
BF”).   
 
Definition of MetS 
To date, no standard definition of MetS for children/adolescents has been 
established213. For this analysis, MetS was categorized using a definition proposed by Cruz 
et al.14 that applies pediatric cutoffs to the Adult Treatment Panel III definition217. MetS 
was defined as having at least three of the following risk factors: abdominal obesity (waist 
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circumference ≥90th percentile for age, sex, and Hispanic ethnicity from NHANES III 
data), elevated blood pressure (systolic or diastolic blood pressure >90th percentile adjusted 
for height, age, and sex), low HDL cholesterol (HDL cholesterol ≤10th for age and sex), 
hypertriglyceridemia (triglycerides ≥90th percentile of age and sex), and impaired glucose 
tolerance (IGT). Participants with MetS were classified into four groups18: “NEVER 
(negative for MetS at all annual visits); EVER (positive for MetS at any annual visits); 
INTERMITTENT (positive for MetS at 1 or 2 annual visits); and PERSISTENT (positive 
for MetS at ≥3 annual visits)”.  
Definition of Prediabetes 
Prediabetes was defined according to American Diabetes Association (ADA) 
diagnostic criteria, as FPG levels between 100 and 125 mg/dL (between 5.6 and 6.9 
mmol/L) and /or IGT, 2-hour plasma glucose value of at least 140 and less than 200mg/dl, 
and/or HbA1c values between 5.7–6.4% (39–47 mmol/mol.)194. Similar to MetS, 
participants with prediabetes were classified into four groups: “NEVER (negative for 
prediabetes at all annual visits); EVER (positive for prediabetes at any annual visits); 
INTERMITTENT (positive for prediabetes at 1 or 2 annual visits); PERSISTENT (positive 
for prediabetes at ≥3 annual visits)”.  
Statistical Analysis 
Summary statistics, graphical analyses, and frequency distributions were used to 
describe the data.  Descriptive statistics (i.e., mean, standard deviation, range, median and 
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quartiles, histograms and Q-Q plots) assessed the distribution of the data. First, t-tests and 
chi-square analyses were performed to assess differences in baseline and physical 
characteristics between GDM and non-GDM offspring. Next, multinomial logistic 
regressions evaluated the effects of BF, GDM, and BF-GDM interaction on the prevalence 
of MetS and prediabetes over time with sex, Tanner stage, age, total body fat percentage, 
and birth weight as covariates. All analyses were performed using SAS version 9.4 (SAS, 
North Carolina, USA). A p value of 0.05 was used to denote significance. 
RESULTS 
Of the 229 children, 26% (n=60) of children were exposed to GDM in utero and 
57% (n=130) were breastfed for at least one month. Table 5 displays baseline descriptive 
characteristics of the GDM and non-GDM participants. GDM offspring compared to non-
GDM offspring had higher birthweight at baseline. There were no differences in age, sex, 
Tanner stage, overweight/obesity prevalence, breastfeeding status, and MetS prevalence 
between GDM and non-GDM participants at baseline. Approximately 60% were male with 
an average age of 11 years at baseline, and 80.1% had obesity. Fifty-seven percent were 
breastfed for ≥ 1 month, with an average duration of 5.2 ± 7.5 months. Approximately 25% 
had MetS at baseline. GDM offspring compared to non-GDM offspring had a higher 
prevalence of prediabetes at baseline (~58% vs. 33%, p=0.03). 
Tables 6 and 7 compare baseline physical and metabolic characteristics of the 
participants with their prediabetes and MetS status (i.e.; never, ever, intermittent, and 
persistent), respectively. There were no differences in age, sex, Tanner stage, and 
 47 
birthweight of the participants at baseline and their prediabetes and MetS status at the latest 
visit. There were significant differences between weight, waist circumference, total body 
fat, and overweight/obesity prevalence at baseline and MetS categories (Table 7). 
However, this result was attenuated for the prediabetes groups (Table 6). There were 
significant differences between GDM status (i.e.; being born to GDM vs. non-GDM 
mothers), BF status, BF duration, and fasting blood glucose level at baseline and 
prediabetes and MetS categories at the latest visit. 
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Table 5. Comparison of baseline physical and metabolic characteristics between GDM and non-GDM offspring 
Variablea  Total (n=229)  Non-GDM (n=169)  GDM (n=60)  P-valueb 
Male, n (%)  131.0 (57.2)  106.0 (58.6)  25.0 (52.1)  0.42 
Age (years)  11.1 ± 1.6  11.0 ± 1.6  11.1 ± 1.6  0.40 
Birth weight (kg)  3.7 ± 0.9  3.5 ± 0.9  3.9 ± 0.9  0.03 
Weight (kg)  71.7 ± 19.7  69.8 ± 17.9  75.2 ± 23.0  0.06 
Waist circumference (cm)  92.3 ± 13.5  91.1 ± 13.1  93.4 ± 14.9  0.19 
Total body fat (kg)  29.1 ± 11.4  26.9 ± 10.1  31.2 ± 12.9  0.48 
Tanner stage, n (%)         
1- 3  157.0 (68.6)  118.0 (69.9)  39.0 (64.7)  0.87 
4-5  72.0 (31.4)  51.0 (30.1)  21.0 (35.3)   
Overweight/obese status, n (%)       
Overweight (>85th-<95th percentile) 44.0 (19.2)  32.0 (18.9)  12.0 (20.6)  0.46 
 Obese (≥95th percentile)  185.0 (80.1)  137.0 (81.1)  48.0 (79.4)   
Breastfeeding status, n (%)         
<1 month  99.0 (43.2)  68.0 (40.2)  31.0 (50.9)  0.08 
≥1 month  130.0 (56.8)  101.0 (59.8)  29.0 (49.1)   
BF duration (months)  5.2 ± 7.5  5.4 ± 7.8  4.6 ± 7.2  0.59 
FPG (mg/dL)  92.4 ± 6.7  91.7 ± 6.2  93.1 ± 7.9  0.81 
Metabolic Syndrome, n (%)  57.0 (24.9)  42.0 (25.0)  15.0 (25.5)  0.24 
Prediabetes, n (%)  91.0 (39.7)  56.0 (33.3)  35.0 (57.6)  0.003 
a Values are mean ± SD unless otherwise stated. 
b t-tests and chi-square tests were run to assess difference in means or % between non-GDM and GDM groups.  
Significant p-values (< 0.05) are bolded. 
GDM: Gestational Diabetes Mellitus 
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Table 6. Comparison of baseline physical and metabolic characteristics by prediabetes (PreDM) groups at the latest visit 




PreDM (n=61)  
Persistent 
PreDM (n=59)  P-value
b 
Male, n (%)  61.0 (56.0)  70.0 (58.3)  33.0 (54.1)  37.0 (62.7)  0.59 
Age (years)  11.2 ± 1.7  11.0 ± 1.8  11.0 ± 1.8  11.0 ± 1.7  0.86 
Birth weight (kg)  3.7 ± 0.9  3.6 ± 0.7  3.6 ± 0.7  3.5 ± 0.8  0.40 
Weight (kg)  65.9 ± 19.9  64.6 ± 20.0  62.5 ± 16.2  66.7 ± 23.2  0.45 
Waist circumference (cm)  88.9 ± 14.6  88.6 ± 12.5  87.9 ± 11.0  89.4 ± 13.9  0.82 
Total body fat (kg)  25.4 ± 10.7  25.3 ± 10.2  24.2 ± 8.3  26.4 ± 11.8  0.52 
Tanner stage, n (%)           
1- 3  81.0 (74.3)  98.0 (81.7)  52.0 (85.2)  46.0 (78.0)  0.16 
4-5  28.0 (25.7)  22.0 (18.3)  9.0 (14.8)  13.0 (22.0)   
Overweight/obese status, n (%)           
Overweight (>85th-<95th percentile)  24.0 (22.0)  16.0 (13.3)  6.0 (9.8)  10.0 (16.9)  0.13 
Obese (≥95th percentile)  84.0 (77.1)  104.0 (86.7)  55.0 (90.2)  49.0 (83.1)   
GDM* status, n (%)           
Non-GDM  97.0 (89.0)  84.0 (70.0)  48.0 (78.7)  36.0 (61.0)  0.001 
GDM  12.0 (11.0)  36.0 (30.0)  13.0 (21.3)  23.0 (39.0)   
Breastfeeding status, n (%)           
<1 month  32.0 (29.4)  64.0 (53.3)  30.0 (49.2)  34.0 (57.6)  0.001 
≥1 month  77.0 (70.6)  56.0 (46.7)  31.0 (50.8)  25.0 (42.4)   
BF duration (months)  6.7 ± 8.6  4.0 ± 6.4  3.4 ± 5.6  4.5 ± 7.1  0.02 
FPG (mg/dL)  92.8 ± 6.1  94.5 ± 7.5  93.2 ± 7.3  95.8 ± 7.5  0.03 
a Values are mean ± SD unless otherwise stated. 
b ANOVA test was run to assess difference in means or % between metabolic outcomes and baseline variables.  
*  Significant p-values (< 0.05) are bolded. 
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Table 7. Comparison of baseline physical and metabolic characteristics by Metabolic Syndrome (MetS) groups at the latest 
visit 
Variablea  Never MetS (n=117)  
Ever MetS  






Male, n (%)  60.0 (51.3)  49.0 (60.0)  29.0 (61.7)  20.0 (58.8)  0.29 
Age (years)  11.2 ± 1.7  11.0 ± 1.8  11.0 ± 1.8  11.0 ± 1.5  0.45 
Birth weight (kg)  3.7 ± 0.7  3.5 ± 0.9  3.5 ± 0.7  3.6 ± 1.0  0.71 
Weight (kg)  63.7 ± 19.9  66.9 ± 19.3  66.9 ± 19.8  64.5 ± 18.8  0.04 
Waist circumference (cm)  87.4 ± 13.5  90.1 ± 13.3  91.1 ± 13.3  89.1 ± 13.3  0.00 
Total body fat (kg)  24.5 ± 10.5  26.1 ± 10.6  26.1 ± 10.5  26.1 ± 10.6  0.004 
Tanner stage, n (%)           
1- 3  88.0 (75.2)  64.0 (79.0)  37.0 (78.7)  27.0 (79.4)  0.53 
4-5  29.0 (24.8)  17.0 (20.0)  10.0 (21.3)  7.0 (20.6)   
Overweight/obese status, n (%)           
Overweight (>85th-<95th 
percentile) 
 26.0 (22.2)  11.0 (13.6)  4.0 (8.5)  7.0 (20.6)  0.001 
Obese (≥95th percentile)  91.0 (77.8)  70.0 (86.4)  43.0 (91.5)  27.0 (79.4)   
GDM status, n (%)           
Non-GDM  95.0 (81.2)  58.0 (71.6)  35.0 (74.5)  23.0 (67.6)  0.001 
GDM  22.0 (18.8)  23.0 (28.4)  12.0 (25.5)  11.0 (32.4)   
Breastfeeding status, n (%)           
<1 month  29.0 (24.8)  53.0 (65.4)  31.0 (66.0)  22.0 (64.7)  0.001 
≥1 month  88.0 (75.2)  28.0 (34.6)  16.0 (34.0)  12.0 (35.3)   
BF duration (months)  7.1 ± 8.1  3.0 ± 5.9  2.5 ± 5.4  3.5 ± 6.3  0.002 
FPG (mg/dL)  91.2 ± 4.8  95.6 ± 6.4  95.7 ± 6.2  95.4 ± 6.6  0.048 
a Values are mean ± SD unless otherwise stated. 
b ANOVA test was run to assess difference in means or % between metabolic outcomes and baseline variables.  
*  Significant p-values (< 0.05) are bolded.
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Results from the multinomial logistic regression for prevalence of prediabetes are 
shown in Table 8. Of the 229 children, 27% and 26% had intermittent and persistent 
prediabetes across time, respectively. Males had three times higher persistent prediabetes 
than females (p=0.04). Total body percent fat, and Tanner stage did not differ across 
intermittent and persistent prediabetes groups. However, odds of ever prediabetes was four 
times higher for those in Tanner stage 4-5 than those in Tanner stage 1-3 (p<0.001). Age 
of the participants with ever prediabetes was significantly higher than those who never had 
prediabetes. GDM offspring compared to non-GDM offspring had approximately four, two 
and a half, and six times higher odds of ever, intermittent, and persistent prediabetes, 
respectively (p=0.0002; p=0.03; p<0.001). Children who were breastfed for at least one 
month had significantly lower odds of ever, intermittent, and persistent (p=0.0009; 
p=0.001; p=0.002) than those who were never breastfed or breastfed for less than one 
month. 
There was an overall significant BF-GDM interaction on the prevalence of 
prediabetes (p=0.04). “GDM, no-BF” group was entered in the model as the referent group 
for Bonferroni post hoc comparisons and all prediabetes groups were compared to the 
“never prediabetes” group. Compared to the referent group, “non-GDM, BF” group had 
lower odds of ever prediabetes (OR=0.07, 95%CI: 0.02-0.24, p<0.0001), intermittent 
prediabetes (OR=0.12, 95%CI: 0.03-0.49, p=0.003), and persistent prediabetes (OR=0.04, 
95%CI: 0.01-0.11, p<0.001). Compared to the referent group, “non-GDM, no BF” group 
had lower odds of ever and persistent prediabetes (OR=0.10, 95%CI: 0.03-0.39, p=0.001; 
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OR=0.10, 95%CI: 0.03-0.39, p=0.001); however, the prevalence of intermittent 
prediabetes was not significant for the mentioned group.  
Among GDM offspring, those who were breastfed compared to those not breastfed 
had lower odds of persistent prediabetes (OR=0.10, 95%CI: 0.03-0.41, p=0.02); however, 
this result was attenuated for the prevalence of intermittent prediabetes. Among non-GDM 
offspring, those who were breastfed compared to those not breastfed had lower odds of 
intermittent prediabetes (OR=0.23, 95%CI: 0.10-0.54, p<0.001) and persistent prediabetes 
(OR=0.29, 95%CI: 0.06-0.28, p=0.01). Figure 1 displays the results in terms of frequency 











Figure 1. Frequency of each type of prediabetes by BF- GDM groups.  
Never=negative for prediabetes at all annual visits; Ever = positive for 
prediabetes at any visit; Intermittent=positive for prediabetes at 1 or 2 visits; 






























































Table 8. Logistic multinomial regression of physical and early life predictors on the prevalence of ever, intermittent, and 
persistent prediabetes  
Predictors  Ever Prediabetes (n=120)  Intermittent Prediabetes (n=61)  Persistent Prediabetes (n=59) 
  Pa  ORb (95% CI)  Pa  ORb (95% CI)  Pa  ORb (95% CI) 
Covariate Adjusted Additive Model for GDM and BF Status Separate 
GDM                   
No  Referent  1.00  -----  1.00  -----  1.00 
Yes  0.0002  3.67 (1.87, 7.20)  0.03  2.40 (1.09, 5.29)  <0.001  5.60 (2.59, 12.06) 
Breastfeeding (BF)                 
No Referent  1.00  -----  1.00  -----  1.00 
Yes  0.0009  0.38 (0.22, 0.67)  0.002  0.29 (0.13, 0.61)  0.001  0.26 (0.11, 0.58) 
Covariate Adjusted GDM Groups Stratified by BF Status 
GDM, no BF Referent  1.00  -----  1.00  -----  1.00 
GDM, BF  0.01  0.15 (0.03, 0.67)  0.59  0.63 (0.11, 1.99)  0.02  0.18 (0.04, 0.82) 
Non-GDM, no BF 0.001  0.10 (0.03, 0.41)  0.35  0.50 (0.12, 2.13)  0.001  0.10 (0.03, 0.39) 
Non-GDM, BF <0.0001  0.07 (0.02, 0.24)  0.003  0.12 (0.03, 0.49)  <0.001  0.05 (0.01, 0.11) 
Sex                   
Female Referent  1.00  -----  1.00  -----  1.00 
Male  0.05  1.84 (0.99, 3.43)  0.45  1.44 (0.56, 3.62)  0.04  2.98 (1.05, 8.45) 
Total Body % Fat 0.23  1.03 (0.98, 1.08)  0.28  1.03 (0.98, 1.09)  0.36  1.03 (0.97, 1.09) 
Birthweight  0.06  0.66 (0.43, 1.03)  0.43  0.81 (0.48, 1.38)  0.01  0.47 (0.26, 0.85) 
Age  0.01  1.31 (0.98, 1.58)  0.02  1.23 (1.02, 1.54)  0.03  1.27 (0.99, 1.62) 
Tanner                   
1-3 Referent  1.00  -----  1.00  -----  1.00 
4-5  <0.001  3.91 (1.97, 7.79)  0.05  1.71 (0.48, 6.06)  0.41  3.18 (0.77, 13.21) 
a Significant P-values (< 0.05) are bolded 
b OR: Odds Ratio, p-value for interaction = 0.04 
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Results from the multinomial logistic regressions for prevalence of MetS are shown 
in Table 9. Of the subsample of 198 offspring who were assessed for MetS, 58% never 
had MetS, 25% and 17% had intermittent and persistent MetS, respectively. Males had 
about three times higher odds of intermittent and any type of MetS (p=0.04; p=0.01) and 
five times higher odds of persistent MetS than females (p=0.004). Birthweight, age, and 
Tanner stage did not differ between MetS groups. Compared to offspring who had never 
had MetS, those with ever or persistent MetS had higher total body fat percentage 
(p=0.009; p=0.002). GDM offspring compared to non-GDM offspring had approximately 
four, three and a half, and six times higher odds of ever, intermittent, and persistent MetS, 
respectively (p=0.002; p=0.01; p=0.001). Children who were breastfed for at least one 
month had lower odds of ever, intermittent, and persistent MetS (p<0.001) than those who 
were never breastfed or breastfed for less than one month. 
There was an overall significant BF-GDM interaction on the prevalence of MetS 
(p=0.03). Compared to “GDM, no BF” group (referent), “non-GDM, BF” group, had 
significantly lower odds of ever MetS (OR=0.02, 95%CI: 0.03-0.41, p<0.0001), 
intermittent MetS (OR=0.03, 95%CI: 0.01-0.10, p<0.001), and persistent MetS (OR=0.04, 
95%CI: 0.01-0.11, p<0.001). “Non-GDM, no BF” group had lower odds of persistent MetS 
(OR=0.14, 95%CI: 0.04-0.59, p= 0.01) compared to the “GDM, no BF” group; however, 
this result was attenuated for the prevalence of intermittent MetS. Among GDM offspring, 
those who were BF compared to those not BF had lower odds of intermittent and persistent 
MetS (OR=0.12, 95%CI: 0.02-0.75, p=0.02; OR=0.10, 95%CI: 0.02-0.55, p=0.008).  
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Table 9. Logistic multinomial regression of physical and early life predictors on the prevalence of ever, intermittent, and 
persistent MetS rate 
Predictors  Ever MetS (n= 81)  Intermittent MetS (n=47)  Persistent MetS (n=34) 
  Pa  ORb (95% CI)  Pa  ORb (95% CI)  Pa  ORb (95% CI) 
Covariate Adjusted Additive Model for GDM and BF Status Separate 
GDM             
No Referent  1.00  -----  1.00  -----  1.00 
Yes  0.002  4.29 (1.73,10.64)  0.01  3.47 (1.29, 9.38)  0.001  5.72 (2.01, 13.29) 
Breastfeeding (BF)             
No Referent  1.00  -----  1.00  -----  1.00 
Yes  <0.001  0.05 (0.02, 0.09)  <0.001  0.06 (0.02, 0.18)  <0.001  0.08 (0.03, 0.21) 
Covariate Adjusted GDM Groups Stratified by BF Status 
GDM, no BF Referent  1.00  -----  1.00  -----  1.00 
GDM, BF  0.01  0.18 (0.05, 0.72)  0.02  0.12 (0.02, 0.75)  0.008  0.10 (0.02, 0.55) 
Non-GDM, no BF 0.67  0.76 (0.22, 2.67)  0.81  0.88 (0.18, 4.13)  0.01  0.14 (0.04, 0.59) 
Non-GDM, BF  <0.0001  0.02 (0.03, 0.41)  <0.001  0.03 (0.01, 0.10)  <0.001  0.04 (0.01, 0.11) 
Sex             
Female Referent  1.00  -----  1.00  -----  1.00 
Male  0.01  3.02 (1.25, 7.27)   0.04   2.80 (1.04, 5.08)    0.004    5.18 (2.67, 9.93) 
Total Body % Fat  0.009  1.11 (1.03, 1.19)  0.12  1.07 (0.98, 1.17)  0.002  1.17 (1.06, 1.29) 
Birthweight  0.26  0.72 (0.41, 1.26)  0.49  0.81 (0.44, 1.49)  0.08  0.55 (0.28, 1.08) 
Age  0.48  0.91 (0.69, 1.19)  0.12  0.79 (0.59, 1.05)  0.24  1.22 (0.87, 1.70) 
Tanner             
1-3 Referent  1.00  -----  1.00  -----  1.00 
4-5  0.92  1.05 (0.38, 2.84)  0.40  1.79 (0.53, 2.58)  0.80  1.18 (0.41, 2.73) 
a Significant p-values (< 0.05) are bolded 
b OR: Odds Ratio, p-value for interaction = 0.03
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Among non-GDM offspring, those BF compared to those not BF had significantly 
lower odds of ever, intermittent, and persistent MetS, respectively (OR=0.18, 95%CI: 0.05-
0.72, p=0.01; OR=0.12, 95%CI: 0.02-0.75, p=0.02; OR=0.10, 95%CI:0.02-0.55, p=0.008). 





Figure 2. Frequency of each type of MetS by BF- GDM groups.  
Never=negative for MetS at all annual visits; Ever = positive for MetS at any 
visit; Intermittent=positive for MetS at 1 or 2 visits; Persistent=positive for 























































This study examined the impact of BF and GDM across time on MetS and prediabetes in 
Hispanic offspring born to mothers with and without GDM. Although research shows that BF has 
a protective effect on diminishing development of MetS and prediabetes in offspring, there have 
been conflicting findings and much less is known about this protective effect of BF on children 
born to mothers with GDM. Additionally, no previous studies have examined the persistence of 
MetS and prediabetes in Hispanic offspring exposed to GDM in utero longitudinally. This 
longitudinal study shows that BF has a protective effect on the prevalence of ever and persistent 
MetS and prediabetes in both GDM and non-GDM offspring. 
It is well established that GDM throughout pregnancy is a contributing factor to prediabetes 
and type 2 diabetes in women. While many of the mentioned studies controlled for GDM or type 
of maternal diabetes during pregnancy, few have actually examined the interaction of BF and 
GDM on glucose/insulin action in children164. A prospective cohort of Pima Indians assessed 
protective effects of BF on type 2 diabetes in GDM offspring and found that offspring of mothers 
with GDM (n=21) who were exclusively breastfed had lower prevalence of Type 2 Diabetes, 
compared to those who were not breastfed or were bottle-fed throughout their infancy; however, 
their results were not statistically significant165. The only longitudinal study with quality 
measurements, and quantitative assessment of breastmilk intake was conducted by Gunderson et 
al. and showed that greater BF intensity and duration throughout the first 12 months of life was 
protective against ponderal growth and weight gain among children of mothers with GDM.136 
Another study of offspring born to mothers with GDM (n=29) and Type 1 Diabetes (n=83) 




overweight and IGT at two years of age than breastfed offspring of mothers without diabetes.218 
Their conflicting findings may be due to the heterogeneity of maternal type of diabetes and early 
assessment for prediabetes and overweight in children at or younger than two years of age, which 
is less predictive of overweight and prediabetes status at older ages. Findings of this study show 
that BF has a protective effect on the prevalence of intermittent prediabetes in non-GDM offspring 
and persistent prediabetes in GDM offspring across time. 
While studies show that BF decreases the risks associated with MetS in children and 
adolescents, research on the association between BF and MetS is limited and inconclusive210. A 
recent systematic review of studies that examined the relationship between BF and MetS reported 
that of 11 studies, seven found significant inverse relationships between BF and MetS and four 
studies found no significant associations. One cross-sectional study with 1,770 children and 
adolescents (7-17 years of age) in China, found an inverse association between BF and prevalence 
of MetS. In contrast, a retrospective study by Yakubov et al. with 123 children and adolescents (3-
18 years of age) in Israel showed that BF had no protective effect on the prevalence of MetS.  
However, this study included very young children where MetS might not have yet manifested, 
which may explain their non-significant findings. In addition, the IDF does not suggest MetS 
diagnosis in children younger than 10 years of age. Of note, all of the above studies were conducted 
outside the U.S. and no study has examined the persistence of MetS in offspring born to mothers 
with GDM, or in a high-risk Hispanic population. This study found an inverse association between 
BF and the prevalence of ever, intermittent, and persistent MetS in both GDM and non-GDM 




The mechanisms by which the risk of MetS and diabetes in offspring increases by 
intrauterine exposure to diabetes are not fully understood. Exposure to GDM is associated with 
excess fetal growth and overnutrition in utero, possibly due to hormonal perturbations and 
alterations in expression of genes that direct the accumulation of body fat or related metabolism in 
fetus. Research shows that exposure to maternal diabetes in utero results in hyperglycemia, 
hyperinsulinemia, and leptin resistance in offspring.219 Consequently, exposure to high glucose 
and insulin concentrations increases levels of fatty acids, glucocorticoids, inflammation, and 
radicals of oxygen species (ROS) in the maternal-fetal placenta. Increased intrauterine insulin 
along with generated ROSs can cause altered b-cell differentiation, insulin resistance, and 
consequently increased risk of prediabetes and type 2 diabetes in offspring later in life. 
Additionally, increased ROSs in placenta can alter gene expression and metabolic programming 
of several organs including heart, liver, kidneys, and muscles that can lead to altered insulin 
signaling pathway, reduced bioavailable nitric oxide, vascular stiffness, and diastolic dysfunction 
triggering hypertension and development of MetS in those who were born to mothers with GDM 
throughout adulthood.219 
Very little is understood about the composition of breast milk in mothers with GDM, and 
the precise mechanisms underlying the potential protective effect of BF on diabetes and MetS is 
still unclear. It is believed that exposure to overnutrition and high glucose levels in breast milk of 
women with diabetes during pregnancy may increase obesity and metabolic disease risk in 
offspring later in life. A plausible assumption is that GDM may alter the abundance and 
composition of free human milk oligosaccharides (HMOs), the highest constituent in breast milk 




Infants do not have the necessary enzymes for digestion of HMOs; therefore, they remain 
undigested and will be consumed by specific infant gut microbiota members, which may alter 
metabolic programming and growth and development of offspring later in life. A few studies have 
shown that the glycosylation of protective proteins in milk is lower in women with GDM compared 
to those without GDM. However, no differences were found between the total HMOs and their 
composition in breast milk of women with and without GDM.222 Although a few researchers have 
shown that breast milk from women with glucose intolerance would have adverse effects on health 
outcomes in children, neither the literature nor these findings support this.136 In summary, the 
association between BF and health outcomes in offspring born to GDM mothers remains uncertain 
and further research is needed to investigate the effects of these alterations on offspring health 
outcomes.222 
There are several limitations of the current study to consider. The study sample included 
only Hispanic children with overweight or obesity and with a family history of type 2 diabetes; 
therefore, the results may not be generalizable to Hispanic children of normal weight and other 
ethnic/racial populations. Replication of this study using non-homogenous populations is 
warranted. This study also did not account for GDM mothers receiving treatment, and the severity 
of the GDM was not known. In addition, GDM status was self-reported and was not confirmed 
with medical records; however, validity research has shown self-reported GDM status to be 
accurate with 94% of self-reported GDM cases confirmed by a physician.223 This study did not 
assess maternal or paternal BMI, parity, gestational weight gain, or type of delivery mode (i.e., C-
section vs. vaginal birth) for this study, all of which play a role in subsequent obesity and metabolic 
disease risk in the offspring. Other limitations are that BF was assessed retrospectively and since 




GDM offspring is rather small (n=60) and not enough to examine the various effects of 
breastfeeding duration groups on health outcomes; however, each subject had an average of four 
annual visits with sophisticated adiposity and metabolic testing, which somewhat offsets this 
limitation.   
In conclusion, childhood prevalence of MetS and prediabetes is rising in the U.S., 
especially among Hispanic children and adolescents. This is the first longitudinal study to examine 
the association between BF and the prevalence of metabolic syndrome and prediabetes in Hispanic 
youth with overweight or obesity across puberty. These findings highlight the need to encourage 
mothers diagnosed with GDM during pregnancy to breastfeed for at least one month. 
Breastfeeding is one of the vital modifiable approaches that can have a profound effect on reducing 
the persistence of the metabolic syndrome and prediabetes during adulthood. Continued 
longitudinal analyses using more precise and valid measures such as exclusivity of BF in relation 














Chapter 3: Association of Breastfeeding and Early Exposure to Sugar-
Sweetened Beverages with Obesity Prevalence in Offspring Born to Mothers 
with and without Gestational Diabetes Mellitus 
Vandyousefi S, Whaley SE, Widen EM, et al. Association of breastfeeding and early exposure to 
sugar-sweetened beverages with obesity prevalence in offspring born to mothers with and 




The relationship of Gestational Diabetes Mellitus (GDM), exclusive breastfeeding (EBF), and 
sugar-sweetened beverages (SSBs) on obesity prevalence in children has rarely been evaluated. 
This study examined the association of GDM status, EBF, and SSB with obesity prevalence in 
children (1-5 years of age). Data is from the 2014 Los Angeles County WIC Survey, which 
included 3,707 mothers and their children (1-5 years of age). Compared to GDM offspring who 
were not EBF, GDM offspring who were EBF had lower odds of obesity, as did non-GDM 
offspring who were and were not EBF. Compared to GDM offspring with high SSB intake (>3 
servings/day) and no EBF, GDM offspring with high SSB intake and EBF did not have lower odds 
of obesity, whereas those with GDM, low SSB (≤1 serving/day), and EBF had lower odds of 
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obesity. Using non-GDM, EBF and low SSB as referent, non- GDM offspring who were not EBF, 
with either high or low SSB, had approximately a 4-fold increase in odds of obesity. In GDM 
offspring, EBF is only associated with lower obesity levels if SSB intake is also low, whereas EBF 
is protective against obesity in non-GDM offspring regardless of high or low SSBs intake.  
 



































Childhood obesity has become a serious health concern in the United States (U.S.) 
especially among Hispanic children. In 2015–2016, obesity impacted 18.5% of U.S. children and 
adolescents (2-19 years of age), 13.9% of whom were preschool-aged children (2–5 years of 
age).224,225 In addition, 12.3% of 3-23 months old infants enrolled in the Special Supplemental 
Nutrition Program for Women, Infants, and Children (WIC) in 2014 had high weight-for-length226. 
Hispanic children and infants have the highest obesity prevalence and weight-for-length among all 
racial/ethnic groups, respectively.224,226 Many prenatal and early life factors such as in utero 
exposure to Gestational Diabetes Mellitus (GDM), and early life infant feeding may contribute to 
higher weight gain, obesity, and related metabolic complications in children.7,227  
GDM, defined as “any degree of glucose intolerance with onset or first recognition during 
pregnancy”, is one of the most common metabolic complications of pregnancy worldwide.28 In 
2017, one in seven women were diagnosed with GDM.204 Hispanic women had consistently higher 
prevalence and risk of GDM (9.3%) than non-Hispanic white (NHW) women (7.0%) in the U.S. 
between 2007-2014.205 Intrauterine exposure to GDM is known as one of the contributing factors 
to childhood obesity in offspring.228 Several researchers have shown that women with GDM are 
less likely to exclusively breastfeed in the first hour postpartum and more likely to formula feed 
their children in the hospital than women without GDM.105,106 
Breast milk has been recognized as the best food for infants to meet their daily nutrients 
and energy requirements for the first six months after birth.98 Numerous studies have shown that 
lower breast feeding (BF) duration and intensity increases the likelihood of overweight and obesity 




no other liquids or solids, for at least six months after birth is recommended98,99, only about 25% 
of U.S. infants were exclusively breastfed for 6-months in 2014-2015.101 Hispanics and African 
Americans have lower rates of EBF than NHW mothers in the U.S.27 There is increasing evidence 
that BF has a protective effect against obesity in offspring; however, the impact of EBF in offspring 
exposed to GDM is not well studied or understood.  
Mounting evidence points to sugar consumption, in particular sugar-sweetened beverages 
(SSBs), as a key modifiable factor contributing to obesity and related metabolic disorders.126-129 A 
few studies have reported that children who were breastfed and had limited exposure to SSBs had 
lower obesity prevalence compared to those not breastfed and had higher intake of SSBs.126,191 
While some of the mentioned studies controlled for GDM status, these studies did not examine the 
interaction effect of GDM with early SSBs intake in children (1-5 years of age) on obesity 
prevalence. To date, no study has examined the relationships of EBF, SSBs intake, and GDM 
status on obesity prevalence in offspring (1-5 years of age). Therefore, the goal of this study was 
to examine the individual and interaction effects of EBF, SSB intake, and GDM status on obesity 
prevalence. The current study hypothesized that GDM, EBF, and SSBs would be independently 
associated with lower odds of obesity in offspring, and that there would be an interaction between 
these three factors, with the lowest prevalence of obesity in the group with no GDM, EBF, and 
low SSB intake. 
METHODS 
Data for this study are from the 2014 Los Angeles County (LAC) WIC Survey, the triennial 
WIC household survey adapted from the 2005 LAC Health Survey229, which was designed to 




support for women, infants, and children under age five residing in LAC.230 Data on maternal 
GDM status, child’s birth weight, EBF, and frequency of SSBs intake were collected via a parental 
telephone survey.231 Although the 2014 survey of LAC WIC parents’ questionnaire included 127 
questions, the current study analyzed data on questions related to early life infant feeding practices 
of offspring, GDM status, demographics, ethnic and racial background of the child, and obesity 
measures.232 
For this study, eligible participants were: 1) biological mother of a child enrolled in the 
WIC program, 2) delivered a full-term baby (excluded if delivered a premature or low birth 
weight), and 3) completed the infant feeding survey questions. If a family reported more than one 
WIC eligible child, then data were collected based on the child with the most recent birthdate125. 
Overall 5,000 women and their children (prenatal women through 5-year-olds) participated in LAC 
WIC 2014 however, this study only included 3,707 children (1-5 years of age) and about 470 (or 
approximately 13%) of them were born to mothers with GDM.124 About 1,300 participants were 
excluded from the current analysis because they were pregnant with no children, had infants 
younger than one year of age, or had missing data.  
GDM and Early Life Feeding Measures 
The current study examined EBF, defined as feeding infants exclusively with breast milk 
and no other liquids or solids, for at least six months after birth. The following survey questions 
were asked from the mothers to determine EBF duration: “How old was your child the first time 
(he) (she) was given formula?”, “Are you currently breast-feeding your child?”, “How old was 
your child when you completely stopped breastfeeding (him/her)?”, and “How old was your child 




juice, cow’s milk, sugar water or anything else you fed your baby.” Responses for the last question 
were: “less than one week, one week but less than one month, one month but less than three 
months, three months but less than six months, at six months, or have you not fed your baby 
anything besides breast milk, more than six months”.  
GDM status was analyzed as categorical variables (i.e., “no GDM” who were born to 
mothers without GDM vs. “GDM” who were born to mothers with GDM). To analyze GDM-BF 
interaction, children were divided into four categories based on GDM and EBF status: 1) mothers 
without GDM who EBF (i.e.; “non-GDM, EBF”), 2) mothers without GDM who did not EBF (i.e.; 
“non-GDM, no-EBF”), 3) mothers with GDM who EBF (i.e.; “GDM, EBF”), and 4) mothers 
without GDM who did not EBF (i.e.; “GDM, no-EBF”).  
SSBs variable included all SSBs (excluding 100% fruit juice, diet sodas, and sugar-free 
drinks) and chocolate or flavored milk. SSBs frequency of intake was divided into tertiles to create 
three equal groups as categorical variables (i.e.; low SSB (≤1 serving/day), medium SSB (>1 and 
≤3 servings/day), and high SSB (>3 servings/day)).232 This dietary screener was previously tested 
to assess reliability and validity of sweetened foods and beverages intake among children (2-4 
years of age) against three 24-hour recalls in a subsample of 70 primarily Hispanic mothers.233 
Intraclass Correlation Coefficient (ICC) for total SSB (excluding milk, chocolate milk, and 100% 
fruit juice) yielded to 0.7 (i.e. moderate agreement) and for chocolate or sweetened milk yielded 
to 0.84 (i.e. substantial agreement). Spearman’s rank Correlations Coefficient (SCC) for total SSB 
(excluding milk, chocolate milk, and 100% fruit juice) yielded to 0.46 (i.e. moderate) and for 





To overcome the challenges of accurately assessing a young child’s height and weight in a 
phone survey, survey records were linked to WIC administrative data to obtain accurate 
anthropometric data for the target children. Children were weighed and measured every six months 
by WIC staff. Height, weight, and BMI measurements of children aged 2-5 years obtained by WIC 
staff were previously validated against the standard measurements taken by research staff. 
Sensitivity and specificity of WIC BMI percentile classifications (i.e., overweight/obese versus 
underweight/normal) were high at 86% and 92%, respectively, indicating that WIC staff can 
accurately measure anthropometrics.234 
Definition of Obesity 
Infants (1-2 years of age) with weight-for-height ≥97.7th percentile were classified as high 
weight-for-length.235 Children (2-5 years of age) were classified as subjects with obesity if their 
BMI- for-age was ≥95th percentile, with overweight if their BMI- for-age was  ≥85th percentile236 
and at risk of overweight if their  BMI- for-age was ≥75th percentile. 
Statistical Analysis 
Summary statistics, graphical analyses, and frequency distributions were used to describe 
the data. Descriptive statistics (i.e., mean, standard deviation, range, median and quartiles, 
histograms and Q-Q plots) assessed the distribution of the data. First, t-tests and chi-square 
analyses were performed to assess differences in baseline and physical characteristics between 
GDM and non-GDM offspring. Next, binary logistic regressions evaluated the individual and 




following covariates: child’s age, sex, and race/ethnicity. The dependent variable was obese status, 
i.e., children with obesity (either high weight-for-length for 1-2 y or BMI percentile≥95th for 2-5 
y) were compared to non-obese children. If the interactions with GDM were significant, then the 
group with the least desirable condition was selected as the referent group for Bonferroni post hoc 
comparisons (i.e., GDM offspring who were not EBF and high SSBs intake). All analyses were 
performed using SAS version 9.4 (SAS, North Carolina, USA). A p value of 0.05 was used to 
denote significance. 
RESULTS 
A total of 3,707 children (1-5 years of age) were eligible for this analysis. Of these 
participants, 3,310 had complete data on all variables. About 81% of the participants were of 
Hispanic origin, 13% (n=470) were exposed to GDM in utero, 27% (n=924) were exclusively 
breastfed for at least six months, and 23% (n=865) were high SSBs consumers. Physical 
characteristics, GDM status, EBF, and overweight and obesity rates of the participants are shown 
in Table 10. There were no differences in age and sex between GDM and non-GDM participants. 
Half of the children were male with an average age of three years at the time their mother was 
surveyed. Although GDM offspring had higher birthweight, this difference was not significant. 
Non-GDM offspring were taller than those born to mothers with GDM (p=0.05). Hispanics had 
significantly higher rates of GDM (p=0.007) compared to other ethnicities. Compared to non-
GDM offspring, GDM offspring had similar rates of EBF (25% vs. 27%; p=0.13) but had higher 





Results from the logistic regression for obesity prevalence are shown in Table 11. Nineteen 
percent of children had either high weight-for-length (BMI percentile≥97.7th percentile; 1-2 years 
of age) or obesity (BMI for age percentile≥95th; 2-5 years of age). Males were more likely to have 
obesity than females. However, there were no differences between males and females with BMI- 
for-age ≥85 and 75th percentiles. Birthweight and age were not significant in the model. Hispanics, 
1-5 year of age and 2-5 years of age, were 62% and 46% more likely to have obesity compared to 
NHW children (both p<0.01). Results were consistent with those with overweight and at risk of 
overweight. GDM offspring compared to non-GDM offspring (both 1-5 years of age and 2-5 years 
of age) were more likely to have obesity (OR=1.72 95%CI 1.36-2.19, p<0.0001; OR=2.47, 95%CI 
1.73-3.54, p<0.0001). Similarly, 2-5 years old children who were exposed to GDM in utero were 
more likely to have BMI- for-age ≥85th and 75th percentiles than non-GDM offspring (OR=2.0 
95%CI 1.55-2.70, p<0.0001; OR=1.67, 95%CI 1.27-2.19, p<0.0001). 
 




Table 10. Comparison of physical characteristics between GDM and non-GDM children participating at LAC WIC 
Variablea  Total (n=3,707)  Non-GDM (n=3,237)  GDM (n=470)  P-valueb 
Male, n (%)  1,906.0 (51.4)  1,662.0 (51.3)  244.0 (51.9)  0.84 
Age (years)  2.9 ± 1.2  2.9 ± 1.2  2.9 ± 1.2  0.07 
Birth weight (kg)  3.4 ± 1.8  3.3 ± 1.6  3.5 ± 2.0  0.11 
Weight (kg)  13.8 ± 3.9  13.8 ± 3.8  13.7 ± 4.1  0.52 
Height (cm)  88.8 ± 12.2  88.9 ± 12.2  87.7 ± 12.4  0.05 
Child’s ethnicity         
Hispanics  3,011.0 (81.2)  2,602.0 (80.4)  409.0 (87.0)  0.007 
Non-Hispanic White  122.0 (3.3)  112.0 (3.5)  10.0 (2.1)   
African–American  255.0 (6.9)  233.0 (7.2)  22.0 (4.7)   
Asian Pacific Islander  88.0 (2.4)  76.0 (2.3)  12.0 (2.6)   
Other  231.0 (6.2)  214.0 (6.6)  17.0 (3.6)   
Overweight/obesity status, n (%)         
1-2 years of age:         
High weight-for-length ≥987.7h percentile 236.0 (24.2)  199.0 (24.1)  37.0 (28.5)  0.27 
2-5 years of age:         
At risk (≥75th-<85th percentile) 326.0 (12.6)  230.0 (10.1)  41.0 (12.9)  <0.0001 
     Overweight (≥85th-<95th percentile) 372.0 (14.4)  325.0 (14.3)  47.0 (14.8)   
Obesity (≥95th percentile)  502.0 (19.4)  410.0 (18.0)  92.0 (28.9)   
Exclusive breastfeeding status, n (%)         
<6 months  2,505.0 (72.6)  2,195.0 (72.8)  322.0 (74.8)  0.13 
≥6 months  946.0 (27.4)  820.0 (27.2)  126.0 (25.2)   
SSBs frequency intake         
SSB≤ 1 serving/day  1,184.0 (31.9)  1,032.0 (31.9)  152.0 (32.3)  0.24 
1<SSB≤3 serving/day  1,579.0 (42.6)  1,373.0 (42.4)  206.0 (43.8)   
SSB> 3 serving/day  865.0 (23.3)  765.0 (23.6)  100.0 (21.3)   
GDM = Gestational Diabetes Mellitus; SSBs = Sugar Sweetened Beverages 
a Values are mean ± SD unless otherwise stated. 
b t-tests and chi-square tests were run to assess difference in means or % between non-GDM and GDM groups. Significant P-values (<0.05) are bolded.
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Table 11. Logistic regression of physical and early life predictors on the prevalence of obesity- Main Effects 
  1-5 Years of Age (n=3,310)  2-5 Years of Age (n=2,427) 
  Obesitya  BMI Percentile≥95th  BMI Percentile≥85th  BMI Percentile≥75th 
Variables  Pb  ORc (95% CI)  Pb  ORc (95% CI)  Pb  ORc (95% CI)  Pb  ORc (95% CI) 
Sex                 
Female  Referent 1.00  -----  1.00  -----  1.00  -----  1.00 
Male  0.02  1.21(1.01, 1.40)  0.04  1.22 (1.00, 1.48)  0.67  1.04 (0.87, 1.23)  0.92  0.99 (0.85, 1.17) 
Age  0.14  0.95 (0.89, 1.02)  0.07  1.15 (1.03, 1.29)  0.05  1.19 (1.07, 1.31)  0.07  1.16 (1.05, 1.37) 
Race                 
Non-Hispanics  Referent 1.00  -----  1.00  -----  1.00  -----  1.00 
Hispanics  0.0002  1.62 (0.99, 1.04)  0.007  1.46 (1.11, 1.94)  0.001  1.51 (1.18, 1.93)  0.02  1.29 (1.03, 1.61) 
GDM                 
No  Referent 1.00  -----  1.00  -----  1.00  -----  1.00 
Yes  <0.0001  1.72 (1.36, 2.19)  <0.0001  2.47 (1.73, 3.54)  <0.0001  2.05 (1.55, 2.70)  <0.0001  1.67 (1.27, 2.19) 
Exclusive Breastfeeding (EBF)               
No EBF (<6 mos.)  Referent 1.00  -----  1.00  -----  1.00  -----  1.00 
EBF (≥ 6 mos.)  <0.0001  0.39 (0.31, 0.49)  <0.0001  0.40 (0.28, 0.58)  0.001  0.63 (0.48, 0.83)  0.007  0.69 (0.52, 0.90) 
SSBs Intake  0.03  -----  0.04  -----  0.44  -----  0.51  ----- 
SSB> 3serving/day  Referent 1.00  -----  1.00  -----  -----  -----  ----- 
1<SSB≤3serving/day  0.68  0.78 (0.25, 2.47)  0.66  0.76 (0.23, 2.53)  0.66  -----  -----  ----- 
SSB≤ 1 serving/day  0.04  0.22 (0.05, 0.92)  0.09  0.26 (0.05, 1.28)  0.09  -----  -----  ----- 
                 
aObesity =High weight-for-length/ BMI Percentile≥97.7th (1-2 y) + BMI Percentile≥95th (2-5 y) 
bSignificant p-values (<0.05) are bolded 
cOR: Odds Ratio 
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Children (1-5 years of age and 2-5 years of age) who were EBF had lower odds of obesity 
than those who were not EBF (OR=0.39, 95%CI 0.31-0.49, p<0.0001; OR=0.40, 95% CI 0.28-
0.58, p<0.0001). SSBs intake was independently associated with obesity prevalence in both age 
categories (p=0.03 and p=0.04). However, there were no significant association between SSBs 
intake and having BMI- for-age ≥85th and 75th percentiles. Children 1-5 years of age who were 
low SSB consumers (≤1 SSB serving/day) compared to high SSB consumers (>3 SSB 
servings/day) had lower odds of obesity (OR=0.22, 95% CI 0.05-0.92, p=0.04), whereas the 
Bonferroni comparison was attenuated to a trend for  children 2-5 year of age.  
There was an overall significant EBF-GDM interaction on the prevalence of obesity among 
1-5 years old (p=0.03) and 2-5 years old children (p=0.04). However, the interaction effect was 
attenuated to a trend for 2-5-year-old children with overweight and at risk of overweight. In 1-5-
year olds, compared to GDM children who were not EBF (referent), GDM children who were EBF 
had lower odds of obesity (OR=0.56, 95% CI 0.33-0.95, p=0.03). Compared to GDM children not 
EBF, non-GDM children who were EBF or not EBF both had lower odds of obesity prevalence 
(OR=0.65, 95%CI 0.50-0.85, p=0.001; OR=0.21, 95%CI 0.15-0.30, p<0.0001). In the 2-5-year-
old children, compared to GDM children not EBF, GDM children who were EBF had lower odds 
of obesity (OR=0.57, 95% CI 0.33-0.99, p=0.04). Compared to the referent group, non-GDM 
children who were EBF or not EBF both had lower odds of obesity prevalence (OR=0.54, 95% CI 
0.40-0.73, p<0.001 and OR=0.17, 95% CI 0.11-0.25, p<0.0001). Figure 3 displays the odds of 








Figure 3. Obesity prevalence among 1-5 years old children by GDM-EBF groups 




The current study found no significant GDM-SSBs interaction on the prevalence of obesity 
among 1-5 years old (p=0.26) and 2-5 years old children (p=0.97). However, there was a 
significant GDM-EBF-SSBs interaction on obesity prevalence among 1-5-year olds (p=0.02). This 
relationship was attenuated for all 2-5 years old groups (p>0.05). Bonferroni post-hoc comparisons 
for GDM-EBF and GDM-EBF-SSBs interactions are further displayed in Table 12. 
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Table 12. Logistic regression of physical and early life predictors on the prevalence of obesity-Interaction Effects 
Predictors  1-5 Years of Age (n=3,310)  2-5 Years of Age (n=2,427) 
  Obesitya   BMI Percentile≥95th 
  Pb  ORc (95% CI)  Pb  ORc (95% CI) 
GDM-EBF Interaction  0.03  -----  0.02  ----- 
GDM, No EBF  Referent  1.00  -----  1.00 
GDM, EBF  0.03  0.56 (0.33, 0.95)  0.04  0.57 (0.33, 0.99) 
Non-GDM, No EBF  0.001  0.65 (0.50, 0.85)  <0.001  0.54 (0.40, 0.73) 
Non-GDM, EBF  <0.0001  0.21 (0.15, 0.30)  <0.0001  0.17 (0.11, 0.25) 
         
GDM-SSBs Interaction  0.26  -----  0.97  ----- 
GDM-EBF-SSBs Interactions  0.02  -----  0.14  ----- 
Non-GDM, EBF, Low SSB   Referent  1.00  -----  ----- 
Non-GDM, EBF, High SSB  0.001  1.77 (0.93-3.37)  -----  ----- 
Non-GDM, No EBF, Low SSB  <0.0001  3.62 (2.16-6.05)  -----  ----- 
Non-GDM, No EBF, High SSB  <0.0001  3.83 (2.26-6.48)  -----  ----- 
         
GDM, EBF, Low SSB  Referent  1.00  -----  ----- 
GDM, EBF, High SSB  0.03  4.77 (1.55- 8.60)  -----  ----- 
GDM, No EBF, Low SSB  0.01  4.33 (1.42- 8.07)  -----  ----- 
GDM, No EBF, High SSB  0.01  4.38 (1.39- 8.16)  -----  ----- 
aObesity =High weight-for-length/ BMI Percentile≥97.7th (1-2 y) + BMI Percentile≥95th (2-5 y) 
bSignificant P-values (<0.05) are bolded 
cOR: Odds Ratio  




Figure 4. Obesity prevalence among 1-5 years old children by GDM-EBF-SSBs groups 
*Significantly lower odds compared to referent 
 
In the 1-5-year-old children, compared to GDM offspring, with low SSBs intake, 
and who were EBF (referent), those who were GDM, with high SSBs intake and who were 
EBF had approximately a five-fold increase in odds of obesity (OR=4.77, 95%CI 1.55-
8.60, p=0.03). Compared to the GDM referent group, GDM offspring who were not EBF 
with low and high SSBs intake had 4.3- and 4.4-times higher odds of obesity, respectively 
(OR=4.33, 95%CI 1.42- 8.07, p=0.01; OR=4.38, 95%CI 1.39- 8.16, p=0.01). Using non-
GDM, EBF and low SSB as referent, those who were not EBF, with either high or low 
SSBs had approximately a 4-fold increase in odds of obesity (OR=3.62, 95%CI: 2.16-6.05, 
Non-GDM GDM 
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p<0.0001; OR=3.83, 95%CI: 2.26-6.48, p<0.0001). Compared to the non-GDM referent 
group, those who were EBF and had high SSBs intake had 77% higher odds of obesity 
(OR=1.77, 95%CI 0.93-3.37, p=0.001). Figure 4 exhibits the odds of obesity by EBF-
GDM-SSBs groups among all 1-5-year-old children. 
DISCUSSION 
This study replicated numerous studies before, showing that being exposed to GDM 
in utero is a contributing factor to childhood obesity.82,83,86 A study of 33,893 mothers and 
their offspring (birth-7 years of age) in the U.S. found that the odds of childhood obesity 
were 1.45-fold higher for children born to mothers with GDM versus without GDM.87 
Similarly, a retrospective study of 7,355 children (mean age of 5.8 years) born to mothers 
with GDM in Germany found that the odds of childhood overweight (OR=1.81) and 
obesity (OR= 2.80) were higher for offspring of mothers with GDM, compared to non-
GDM group.88 The current study found that GDM offspring had 1.72 times higher odds of 
obesity than non-GDM offspring. 
The mechanisms by which the risk of obesity in offspring increases by intrauterine 
exposure to diabetes are not fully understood. Exposure to maternal diabetes is associated 
with excess fetal growth in utero, possibly due to fetal hormonal alterations and 
perturbations in fetal fat accretion. Dabelea et al.93 found that exposure to maternal GDM 
in utero results in elevated leptin synthesis, hyperglycemia, and hyperinsulinemia in 
offspring. Moreover, maternal prenatal GDM may also influence and alter the expression 
of genes that direct the accumulation of body fat or related metabolism in fetus.93 
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The current study found a significant interaction effect of GDM and EBF on obesity 
prevalence, and showed that within GDM offspring, those who were EBF compared to 
those not EBF had 44% lower odds of obesity prevalence. Our results are consistent with 
the findings of other studies. A clinical cohort of 15,710 mothers and their offspring in the 
U.S. found an inverse association between breastfeeding and childhood overweight in two-
year-old children who were breastfed for at least six months regardless of GDM status of 
their mothers. Although GDM was not independently associated with childhood 
overweight, it had no effect on the inverse relationship of BF with overweight prevalence 
when included in the model.82 Of note, the above study examined only overweight status 
of two-year-old children without differentiating EBF from mixed BF. A retrospective study 
of 2,295 children (2-4 years of age) of Hispanic mothers with GDM during pregnancy 
showed that offspring who were breastfed for at least 12 months had a 72% decrease in 
obesity prevalence.124 The only longitudinal study with quantitative assessment of 
breastmilk intake was conducted by Gunderson et al. and showed that greater BF intensity 
and duration throughout the first 12 months of life was protective against ponderal growth 
and weight gain among children (birth-12 months of age) of mothers with GDM.136 
In contrast to the current findings and findings of the above studies, a prospective 
cohort of 1,152 Asian women with GDM (n=181) in Singapore reported that offspring of 
mothers without GDM who were breastfed for at least four months had slower growth rate 
from birth to 36 months of age than those who were not breastfed or were BF for less than 
four months; however, they did not find similar results in offspring of mothers with 
GDM138. In the GDM offspring, greater breast milk intake was associated with accelerated 
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weight gain and BMI in the first six months of age. Of note, this study did not differentiate 
exclusive and predominant (full) BF groups, which might explain their conflicting findings. 
Similarly, a study of 112 infants (0-2 years of age) born to mothers with GDM by 
Rodekamp et al. showed a significant association between EBF (any duration) and 
increased childhood relative body weight and blood glucose at two years of age; however, 
after adjustment for the volume of breast milk consumed during the first week of life, all 
these associations were eliminated.139 
Research is sparse on the relationship among GDM status, EBF, and childhood 
obesity and very little is understood about the composition of breast milk in women with 
diabetes during pregnancy. In a prospective longitudinal study, Logan et al. used MRI and 
spectroscopy to determine adipose tissue (AT) quantity and distribution and 
intrahepatocellular lipid (IHCL) content of 86 infants over the first 12 postnatal weeks and 
found that GDM offspring who were EBF had significantly greater total AT volume at 10 
weeks than infants of non-GDM women. However,  they found no significant differences 
between AT distribution and IHCL content of GDM and non-GDM groups at 11 days or 
10 weeks postpartum.92 Human milk oligosaccharide (HMOs) are one of the key 
components in human milk that may protect against chronic diseases. Although evidence 
linking HMOs to childhood obesity is inconclusive, HMOs are known to serve as a fuel for 
human milk microbiota and help develop healthy gut microbiome in breastfed infants. The 
gut microbiota affects regulation of the expression of genes that are involved in fat 
metabolism and deposition and is linked to reduced obesity rates in children.237 No 
differences between the total HMOs in breast milk of women with and without GDM has 
 81 
been reported.222 Therefore, it is unknown whether milk of mothers with GDM can be 
protective against obesity in offspring and more research on other components such as 
leptin and insulin levels in the breast milk of women with GDM is required. 
The current study findings are consistent with other studies and showed that 
children (1-5 years of age) who were EBF for at least six months and had low SSBs intake 
(i.e.; ≤ 1 serving per day) had lower odds of obesity than those with high SSBs intake (i.e.; 
>3 servings per day) regardless of GDM status of their mothers throughout pregnancy. In 
a 10-year longitudinal cohort of over 200 Hispanic adolescents as they traverse through 
puberty (8-19 years of age), high SSBs intake had consistently been linked to increased 
adiposity and type 2 diabetes risk factors.189,190 Davis et al. found that the combination of 
BF ≥12 months and limited exposure to SSBs intake was linked to a 65% reduction in 
obesity prevalence in 2,300 primarily Hispanic children (2-4 years of age) participating in 
WIC clinics in Los Angeles, CA.191 In another separate cohort of 1,483 primarily Hispanic 
children (2-4 years of age) participating in WIC, children who were not breastfed and 
consumed ≥2 SSBs per day had 60% higher obesity rates compared to children breastfed 
for ≥12 months and had no SSBs intake.126 Similarly, in a longitudinal study of low-income 
African American children (3–5 years of age), SSBs intake was positively associated with 
10-20% increase in the prevalence of obesity after two years.192 
Of note, all of the above studies simply controlled for GDM status of mothers and 
did not examine the interaction of SSB, GDM, and EBF. To our knowledge, this is the first 
study that has examined the relationship among GDM status, EBF, and early exposure to 
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SSBs and their independent associations with obesity prevalence in children (1-5 years of 
age). Our results showed a significant GDM-EBF-SSBs interaction. In non-GDM offspring 
(1-5 years of age), EBF was protective against odds of obesity in both high and low SSBs 
consumers; however, EBF was more protective against obesity in low SSBs consumers. In 
GDM offspring, EBF was only protective against obesity when SSBs intake was low. 
Surprisingly, GDM offspring that were EBF and had high SSBs consumption, had similar 
4- to 5-fold increase in odds of obesity compared to those not EBF with either low or high 
SSBs intake. These results suggest that interventions should focus on the combined 
protective effects of EBF and low SSBs intake particularly in GDM offspring.  
There are several limitations of the current study to consider. The study sample 
included predominantly Hispanic participants; therefore, the findings may not be 
applicable to other populations. Replication of this study using heterogenous populations 
are warranted. Another limitation of the current study is that height and weight of some of 
the participants were measured several months apart from their interview date; therefore, 
BMI status may not be reflective of their BMI at the date of the interview. However, EBF 
was retrospectively collected on children 1-5 years of age, and height and weight measures 
were collected on the children at a later visit, when the child was between the ages 1-5 
years. The current study also did not account for GDM mothers receiving treatment, and 
the severity of the GDM was not known. The current study did not assess maternal or 
paternal BMI, parity, or type of delivery mode for this study, all of which play a role in 
subsequent obesity and metabolic disease risk in the offspring. In addition, GDM status 
was self-reported and was not confirmed with medical records; however, validity research 
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has shown self-reported GDM status to be accurate with 94% of self-reported GDM cases 
confirmed by a physician.223 
This is the first study, to our knowledge, that assessed the interaction effects of 
EBF, SSBs intake, and GDM on the prevalence of obesity in predominantly Hispanic 
children. This study found that exposure to GDM and high SSB intake are independently 
associated with higher risk of obesity whereas EBF is independently associated with lower 
risk of obesity. This study also found that within GDM offspring, EBF is only associated 
with lower obesity levels if SSB intake is also low, whereas EBF is protective against 
obesity in non-GDM offspring regardless of high or low SSBs intake. These findings 
highlight the need for interventions targeting mothers with and without GDM to focus on 
promoting EBF and limiting SSBs intake in their children during the first years of life. 
Although EBF was associated with lower adds of obesity in offspring exposed to GDM in 
utero, this study suggests that the combination of EBF and low SSBs intake is still needed 
to combat childhood obesity. 
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Chapter 4: Independent Associations of Breastfeeding, and Sugar-
Sweetened Beverages and 100% Fruit Juice During the First Year of 
Life with Subsequent Overweight and Obesity in Young Children 
Exposed to Gestational Diabetes Mellitus in utero 
Vandyousefi S, Davis JN et al. Independent Associations of Breastfeeding, and Sugar-
Sweetened Beverages and 100% Fruit Juice During the First Year of Life with Subsequent 
Overweight and Obesity in Young Children Exposed to Gestational Diabetes Mellitus in 




This prospective study assessed the relation of breastfeeding (BF) measures and sugar-
sweetened beverages (SSBs) and fruit juice intake during the first year of life to subsequent 
overweight and obesity among young children (ages 2-5y) exposed to gestational diabetes 
(GDM) in utero. The analysis utilized data from the Study of Women, Infant Feeding and 
Type 2 Diabetes after GDM (SWIFT), a prospective, observational cohort of 1,035 women 
with GDM who delivered ≥35 weeks gestation (2008-2011) and attended in-person 
research visits annually from 6-9 weeks through 2 y postpartum. Mothers completed 
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monthly mailed surveys on breastfeeding and infant diet from birth to 1 y including intake 
of SSB, fruit juice, or No SSB/juice. Anthropometry and health at birth and 2-5 y (2013-
2016) were obtained from electronic health records (n=845). Logistic regression models 
estimated adjusted odds ratios (aOR) and (95%CI) for infant diet intake with child (2-5 y) 
overweight (BMI ≥85th to <95th ) or obesity (BMI≤95th percentile) adjusted for covariates 
(maternal age, BMI, GDM severity, income, race/ethnicity, newborn outcomes). Of 845 
GDM infants, there were 52% male, 30% Hispanic, 23% Non-Hispanic White and 37% 
Asian, 60% BF≥6 mos., and 17% had SSB, and 51% had 100% fruit juice during the first 
year. Compared to normal weight children, those with obesity had shorter BF duration (6.1 
vs 9.4 mos.; all p<0.0001) and were more likely to drink SSBs (26% vs 16%) and fruit 
juice (58% vs 50%); (all p=0.007). Breastfeeding duration and SSB and fruit juice intake 
were each independently associated with child obesity (all p<0.05). Compared to those 
BF≥6 mos. and with no SSB, those BF≥6 months with SSBs and Any fruit juice, had three- 
and 4-fold higher odds of obesity, respectively (aOR=2.9 95%CI:1.1-7.3; p=0.03, and 
aOR=3.6; 95%CI:1.2-11.5; p=0.02). Those BF<6 mos. with Any SSB and Any juice intake 
were 5- and 7.5-fold more likely to have obesity (aOR=4.6; 95%CI:1.9-11.8; p=0.001, and 
aOR=7.5, 95%CI:2.7-21.1, p<0.0001). This is the first study to prospectively evaluate BF 
and SSB and fruit juice intake during infancy in relation to subsequent weight status among 
children of GDM mothers. Longer BF and avoidance of SSB and fruit juice in early life 
may ameliorate future obesity in this high-risk population.  
 
Keywords: Gestational diabetes mellitus, breastfeeding, infant diet, Sugar-Sweetened 
Beverages, 100% Fruit Juice, childhood obesity, Body Mass Index 
 86 
INTRODUCTION 
In the United States (U.S.), the prevalence of childhood obesity has increased and 
become a major health issue. Nearly one in five children and adolescents in U.S. are 
affected by obesity. In 2015-2016, the prevalence of overweight and obesity among U.S. 
children and adolescents (2-19 years of age) was 16.6% and 18.5%, respectively, about 
14% of them being young children (2–5 years of age) with obesity.1,238 Many prenatal 
effects like intrauterine exposure to gestational diabetes mellitus (GDM) as well as early 
life factors such as limited breastfeeding (BF) status, early age of introduction to 
complementary foods, or intake of sugar sweetened beverages (SSB) intake or fruit juice 
during infancy may contribute to higher weight gain, obesity, and metabolic complications 
among  children.7,125,136,137,239,240 
GDM, defined as “any degree of glucose intolerance with onset or first recognition 
during pregnancy”, is one of the most common metabolic complications of pregnancy, 
affecting 2-10% of all pregnant women annually in the U.S.,28 and up to 28% worldwide 
depending on population characteristics.241  Elevated blood glucose in women with GDM 
passes through the placenta, increasing the blood glucose and insulin levels in their fetuses. 
Consequently, the fetus receives more energy than their requirements for growth, and 
therefore develop higher fat stores than those of mothers without GDM. There is also 
mounting evidence that intrauterine exposure to GDM may impact the fetal programming 
of obesity and metabolic disorders in offspring.242 Therefore, offspring born to mothers 
with GDM have higher risk of being born with macrosomia and developing obesity later 
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in life.243 Although many studies have reported that offspring born to mothers with GDM 
are more likely to develop obesity and have accelerated BMI growth later in life 206,228,244, 
only a few studies, including those conducted by this lab, have prospectively assessed the 
infant growth136,138,245 or weight status among young children aged 2-5 years exposed to 
GDM in utero.137,240  
One of the factors decreasing risk of childhood obesity is feeding infants with breast 
milk. Breast milk has been recognized as the best source of nutrients for infants. Research 
shows that BF lowers the risk of obesity later in life by 26 percent.136 While EBF for the 
first six months of a child’s life is recommended 98,99, only about 25% of U.S. infants are 
EBF for 6-months 101 Women with GDM are less likely to EBF in the first hour postpartum 
and more likely to formula feed their children in the hospital than women without GDM 
105,106.  A recent study by Gunderson et al. reported an inverse association between BF 
intensity and duration and infant ponderal growth and weight gain from birth to one year 
among GDM offspring.136 Early exposure to SSBs and pure fruit juice are postnatal factors 
that may increase the risk of obesity in children. Considerable amount of calories (7.3% of 
total caloric intake) in the diet of U.S. children comes from SSBs.246 In 2011-2014, about 
63% of U.S. children and adolescents (2-19 years of age) consumed at least one SSB per 
day.246 Intake of SSBs during infancy tracks into childhood, particularly consuming at least 
one SSB per day at age six years.247 Findings are inconsistent with regard to early exposure 
to 100% fruit juice and obesity.248  
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The current study is the first to prospectively assess BF duration and intensity as 
well as SSBs and 100% fruit juice intake from birth through the first year of life in relation 
to subsequent weight status among children exposed to GDM  in utero. (2-5) In this 
exclusively GDM study sample, the analysis accounts for glucose intolerance severity, 
perinatal outcomes, and sociodemographic as well as numerous early life factors known to 
affect child body weight and growth. Therefore, the overall study goal is to examine how 
early life modifiable factors (i.e., BF duration and intensity, and introduction to SSBs and 
100% fruit juice) impact subsequent obesity prevalence in children aged 2-5 years who 
were exposed to maternal GDM.  
METHODS  
The study subjects were mother-infant pairs enrolled in the Study of Women, Infant 
Feeding and Type 2 Diabetes after GDM (SWIFT), a prospective, observational cohort of 
1,035 women (20-45 years of age) diagnosed with GDM who were recruited during 
pregnancy and delivered a pregnancy of ≥35 weeks’ gestation at a Kaiser Permanente 
Northern California (KPNC) hospital from 2008 to 2011. KPNC participants represent the 
diverse racial and ethnic groups in California. The SWIFT Study utilized quantitative 
methods by Piper et al.249 to assess BF intensity and duration, and evaluate fetal and 
postnatal life exposures (i.e., severity of maternal glucose intolerance, gestational age, 
newborn health outcomes, infant diet and complementary feeding). SWIFT mothers 
consented to three in-person research visits from 6-9 weeks through two years postpartum 
and completed feeding diaries and monthly mailed surveys on infant diet, including BF 
intensity/duration, SSB, fruit juice and food intake from birth to one year. Maternal and 
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neonatal health outcomes, maternal glucose tolerance severity (i.e., 3- hour oral glucose 
tolerance test, gestational age at diagnosis of GDM, GDM treatment), gestational weight 
gain, infant birth weight, and weights and heights in children at ages 2-5 years (2013-2016) 
were obtained from electronic health records (n=845).  
Women were eligible to participate in the SWIFT study if they: 1) were 20-45 years 
old at delivery, 2) delivered a singleton, live birth ≥35 weeks gestation 3) diagnosed with 
GDM, 4) had no history of diabetes or other serious medical conditions (e.g., failure to 
thrive, physical impairment affecting feeding ability, chronic infectious disease, severe 
jaundice, or metabolic disorders), 5) their clinical medical and delivery records from the 
KPNC were available, 6) had no further pregnancy plan for the next two years, 7) were not 
on any medications that alter results of their blood glucose test, and 8) were able to speak 
English or Spanish. Eligibility criteria to participate in the SWIFT study was also based on 
infant feeding practices and intentions. At baseline (6-9 weeks postpartum), mothers with 
GDM were equally distributed into the two infant feeding groups including: 1) intensive 
lactation (breast milk only or <6 oz. per day of formula supplementation within 6-9 weeks 
postpartum, and intention to continue BF intensively for at least four months postpartum) 
and 2)intensive formula feeding (FF) (no breast milk or at least 14 oz. of formula per day 
for the first four months post-delivery) groups.245,250 
This study utilized dietary data collected from birth to 1 year of age: a) interviewer-
administered questionnaires at in-person visits, recorded feeding diaries, and monthly 
mailed questionnaires to report the frequency of BF and FF, including daily amounts of 
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formula fed, and introduction of solids, type and amounts, introduction of fruit juice, 
sweetened beverages, water and other beverages, and type of beverage and amount of that 
beverage; b) anthropometric measures of weight and length at birth; and c) anthropometric 
measurements from pediatric well-child health plan visits from 2-5 years of age from 
electronic medical records.  
Infant Feeding Measures 
The SWIFT study selected mothers who reported they were currently exclusively or 
mostly BF (<6 oz. formula per 24 hours), or exclusively or mostly FF (>14 oz. formula per 
24 hours) at 4-6 weeks postpartum and intending to continue at these same levels for four 
months15.  At enrollment at 6-9 weeks postpartum (study baseline), some women who later 
transitioned to higher amounts of formula feeding were included in the study. BF duration 
(total months) was evaluated as a continuous variable and categorized as never BF, BF <6 
months, and BF ≥6 months.  In addition, type and quantity of first complementary foods, 
fruit juice, and SSBs were categorized by age at initiation for infants. Intake of beverages 
other than milk feeds was categorized as ever consuming SSB, 100% Juice, or No SSB/No 
Juice from birth to 1 year of age during infancy.  
Standardized Clinical Anthropometric Measurements at ages 2 to 5 years 
Clinical measurements of neonates were obtained in the supine position, including 
weight and length, and the size at birth was calculated from KPNC population 
percentiles.251  Children were measured in a standing position with heels against a wall, 
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and weight using a digital scale at ages 2 to 5 years, and these measurements were obtained 
from the electronic medical records.252-254 Weight and heights were used to calculate BMI 
and categorized as normal, overweight or obese based on the CDC growth percentiles.255 
Statistical Analysis 
Summary statistics, graphical analyses, and frequency distributions were used to 
describe the data.  Descriptive statistics (i.e., mean, SD, range, median and quartiles, 
histograms and Q-Q plots) assessed the distribution of the data. All analyses were 
performed with SAS version 9.4 (SAS, North Carolina, USA). Significance was denoted 
at p<0.05. Multinomial logistic regression models estimated odds ratio (95%CI) for infant 
diet (BF duration, intensity, and SSB intake) among the child BMI status categories 
(normal weight=<85th BMI percentile; overweight weight ≥85th-<95th BMI percentile; and 
≥ 95th BMI percentile) based on the CDC growth standards for children ages 2 to 5 years. 
The models estimated adjusted ORs accounting for potential confounders including  
race/ethnicity, parity (Primiparous vs. Multiparous), WIC participation, education level of 
mother (years of formal schooling), severity of prenatal glucose intolerance (3-hr 100g 
OGTT sum of z-scores for glucose at fasting, 1 hr., 2 hr. and 3 hr.), GDM treatment type 
(diet modification only vs. oral hypoglycemic agents or insulin), gestational age at 
diagnosis of GDM, and child age at BMI measurement.  
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RESULTS 
Descriptive Statistics and Correlates 
A total of 845 infants of the SWIFT mothers had dietary intake assessments during 
the first year of life, and weight and height measurements available in the KPNC health 
records at ages 2-5 years to calculate BMI percentiles; 13% of the children had the 
measurements for BMI available at age 4 years or older. About 23% of infants were Non-
Hispanic White, 30% of Hispanic origin, 37% Asian, and 10% were from other races. 
Table 13 shows maternal characteristics among BMI categories for GDM exposed 
children. Maternal age, smoking at baseline, and type of GDM treatment, gestational 
weight gain, and parity did not differ among the child BMI categories. Children with 
obesity had mothers with significantly higher pre-pregnancy BMI (p<0.0001), increased 
GDM severity (prenatal 3-hr 100 g OGTT sum of z-scores) (p=0.002), and lower level of 
education (p<0.0001) than mothers of normal- and overweight children. Additionally, 
children with obesity compared to children with normal weight and overweight had a 
significantly earlier gestational age at maternal GDM diagnosis (mean (SD) gestational 
age, 23.2 (8.7) weeks vs 25.9 (6.7) and 25.7 (6.7) weeks; p= 0.006) and were more likely 
to participate in the Special Supplemental Nutrition Program for Women, Infants, and 
Children (43% vs 28% and 22% ; p<0.0001).  
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Table 13. Maternal characteristics among young children aged 2 to 5 years exposed to GDM in utero. 
Maternal Characteristicsa 




< 85th percentile 
n=647 
Overweight 






Maternal Age (years) 33.4 ± 4.9 33.5 ± 4.8 33.3 ± 4.4 32.7 ± 5.5 0.12 
Education (years) 14.9 ± 2.9 15.1 ± 2.9 14.6 ± 2.7 13.6 ± 2.7 <0.0001 
Race/ethnicity, n (%)      
      Non-Hispanic White 196 (23) 150 (24) 29 (28) 17 (19) 0.002 
      Non-Hispanic Black  68 (8) 47 (8) 8 (7) 13 (14)  
      Hispanic   251 (30) 173 (27) 40 (39) 38 (41)  
      Asian 313 (37) 263 (40) 28 (25) 22 (24)  
      Other  17 (2) 14 (2) 2 (2) 1 (1)  
WIC recipient n (%) 211 (25) 142 (22) 29 (28) 40 (43) <0.0001 
Pre-pregnancy BMI kg/m2 29.5 ± 7.2 28.5 ± 6.8  31.7 ± 8.3 33.4 ± 6.9 <0.0001 
Pre-pregnancy weight status, n (%)      
      BMI < 25 kg/m2 269 (32) 236 (36) 22 (22) 11 (12) <0.0001 
      25 kg/m2 ≤BMI< 30 kg/m2 247 (29) 197 (30) 33 (31) 17 (19)  
      BMI ≥ 30 kg/m2 329 (39) 214 (33) 52 (48) 63 (69)  
Prenatal 3-hr OGTT z-score 0.0 ± 2.7 -0.1 ± 2.6 -0.4 ± 2.4 0.9 ± 3.6 0.002 
GDM Treatment Type, n (%)      
      Diet only 593 (70) 459 (71) 75 (70) 59 (65) 0.45 
      Oral hypoglycemic agents 227 (27) 167 (26) 29 (28) 31 (34)  
      Insulin  25 (3) 20 (3) 2 (2) 1 (1)  
Gestational age at GDM Diagnosis (weeks) 25.5 ± 7.0 25.7 ± 6.7   25.9 ± 6.7 23.2 ± 8.5 0.006 
Gestational weight gain (kg) 10.5 ± 6.9 10.6 ± 6.3 10.2 ± 9.1 10.1 ± 7.5 0.80 
Parity, n (%) birth order      
      Primiparous 325 (38) 240 (38) 48 (45) 33 (36) 0.29 
      Multiparous 520 (62) 407 (63) 59 (55) 58 (64)  
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Table 13. Maternal characteristics among young children aged 2 to 5 years exposed to GDM in utero. 
Maternal Characteristicsa 




< 85th percentile 
n=647 
Overweight 






Gestational weight gain relative to IOM      
      Below IOM 279 (33) 221 (34) 34 (32) 24 (26) 0.32 
      Within IOM 274 (32) 214 (33) 31 (29) 29 (32)  
      Above IOM 292 (35) 212 (32) 42 (40) 38 (42)  
Infant feeding intention score 7.3 ± 1.1 7.3 ± 1.1 7.3 ± 1.0 7.3 ± 1.1 0.92 
Smoking Status at baseline, n (%)      
      Current 28 (3) 9 (3) 4 (4) 5 (6) 0.18 
      Past (Pre-conception) 146 (17) 107 (17) 26 (23) 13 (14)  
      Never 671 (79) 521 (80) 77 (73) 73 (80)  
a Values are mean ± SD unless otherwise stated. 
b t-tests and chi-square tests were run to assess difference in means or % between non-GDM and GDM groups.  
Significant p-values (<0.05) are bolded. 
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Physical characteristics, BF duration and intensity scores, and overweight and 
obesity prevalence of children are shown in Table 14. There were no significant 
differences in child age at the BMI measurement, sex, age of initiation of solids and 
complementary foods, infant feeding intention score, and parity among normal weight 
participants and children with overweight and obesity. About half of the children were male 
with an average age of three years at the time of BMI measurement. Compared to normal 
weight, offspring with overweight and obesity had significantly higher birthweight (3.3 vs. 
3.7 and 3.5 kg.; p<0.0001) and birth length (50.4 vs. 51 and 51 cm; p=0.01). Compared to 
other ethnicities/races, Hispanics had significantly higher rates of overweight (39%) and 
obesity (41%) (p=0.002). Children with  obesity were more likely to be large-for-
gestational age (LGA) compared to those with overweight and normal weight (44% vs. 
25% and 17%; p<0.0001). Participants were breastfed for an average of nine months.  
All children were exposed to GDM in utero, and 60% (n=504) were breastfed for at 
least six months, and 17% (n=141) reported any SSB intake before the first year of life, 
and 51% (n=436) reported any 100% juice intake the first year of life. Compared to 
children with normal and overweight, children with obesity were breastfed for significantly 
shorter period (9.4 and 8.5 vs. 6.1 months; p<0.0001). Children with obesity had 
significantly lower rates of being breastfed for at least six months compared to those with 
normal- and over-weight (40% vs 60% and 62%; p=0.0002). Compared to offspring with 
normal-and over-weight, children with obesity had higher rates of SSBs (26% vs. 16% and 
18%) and 100% fruit juice (58% vs. 50% and 53%) consumption (all p=0.007). Among 
offspring with obesity,  rate of SSBs and 100% fruit juice consumers was significantly 
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higher than those with no SSBs or 100% fruit juice intake (26% and 58% vs. 16%; 
p=0.007). Additionally, offspring with obesity had significantly lower rates of being 
exclusively/mostly breastfed and higher rates of exclusively/mostly being formula fed than 
children with normal-and over-weight (Table 14; all p=0.02).  
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Table 14. Infant characteristics among young children aged 2 to 5 years exposed to GDM in utero. 
Infant Characteristicsa 













Infant sex, n (%)      
      Male 438 (52) 334 (52) 53 (52) 51 (56) 0.80 
Birth weight (g) 3396 ±502 3337 ±492 3532 ±504 3645 ±477 <0.0001 
Birth length (cm) 50.5 ±2.4 50.4 ±2.5 50.9 ±2.3 51.0 ±2.3 0.01 
Size-for-Gestational Age      
      Large (LGA) 181 (21) 114 (17) 27 (25) 40 (44) <0.0001 
      Appropriate (AGA) 645 (77) 515 (80) 79 (74) 51 (56)  
      Small (SGA) 19 (2) 18 (3) 1 (1) 0 (0)  
Gestational age (weeks) 39.0 ±1.2 39.0 ±1.2 39.2 ±1.0 39.1 ±1.2 0.23 
Child age at the BMI measurement (months) 40.6 ±6.2 40.5 ±6.2 40.5 ±6.1 40.9 ±6.4 0.82 
Gestational age, n (%)      
      35-36 weeks 42 (5) 36 (5) 3 (3) 3 (3) 0.22 
      37-39 weeks 597 (71) 464 (72) 74 (68) 59 (66)  
      40 weeks or more 206 (24) 147 (23) 30 (29) 29 (31)  
Birth weight, n (%)      
      1,500 – 2,499 g 25 (3) 24 (4) 1 (1) 0 (0) 0.0002 
      2,500 – 2,999 g 155 (18) 131 (20) 17 (16) 7 (8)  
      3,000 – 3,999 g 571 (68) 435 (67) 73 (68) 63 (69)  
      4,000 g – 4,499 g 75 (9) 45 (7) 12 (11) 18 (20)  
      4,500 g or more 19 (2) 12 (2) 4 (4) 3 (3)  
Breastfeeding duration 2 groups       
      < 6 months 341 (40) 243 (38) 43 (40) 55 (60) 0.0002 
      ≥ 6 months 504 (60) 404 (62) 64 (60) 36 (40)  
Breastfeeding intensity groups at 6-9 weeks     
      Exclusively Breast Feeding 185 (22) 150 (23) 25 (23) 10 (11) 0.0206 
      Mostly Breast Feeding 344 (41) 270 (42) 42 (39) 32 (35)  
      Mostly Formula Feeding 178 (21) 131 (20) 22 (20) 25 (27)  
      Exclusively Formula Feeding 138 (16) 96 (15) 18 (18) 24 (27)  
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Table 14. Infant characteristics among young children aged 2 to 5 years exposed to GDM in utero. 
Infant Characteristicsa 













Breastfeeding Intensity and Duration sum of 
ratios (Birth to 6 months) 
3.9 ± 2.3 3.9 ± 2.2 3.7 ± 2.2 2.8 ± 2.3 <0.0001 
Breastfeeding Intensity and Duration sum of 
ratios (Birth to 12 months) 
6.0 ± 4.6 6.4 ± 4.6 5.5 ± 4.2 4.2 ± 4.3 <0.0001 
Breastfeeding Intensity and Duration sum of 
ratios (Birth to 12 months), Groups 
     
      Score < 3 308 (37) 218 (33) 39 (36) 51 (56) 0.0002 
      Score ≥ 3 537 (63) 429 (67) 68 (64) 40 (44)  
      Score < 6 447 (53) 319 (49) 62 (56) 66 (72) <0.0001 
      Score ≥ 6 398 (47) 328 (51) 45 (44) 25 (28)  
      Score < 9 522 (64) 395 (60) 80 (74) 72 (79) 0.0002 
      Score ≥ 9 293 (36) 252 (40) 27 (26) 19 (21)  
Beverage feeding      
      Sugar Sweetened Liquids ever 141 (17) 99 (16) 19 (18) 23 (26) 0.007 
      100% Fruit Juice  436 (51) 326 (50) 57 (53) 53 (58)  
      None 268 (32) 222 (34) 31 (29) 15 (16)  
Initiation of solid foods      
      ≤ 4 months (Early) 133 (16) 97 (15) 16 (15) 20 (22) 0.24 
      > 4 months (Later) 712 (84) 550 (85) 91 (85) 71 (78)  
      ≤ 6 months (Early) 657 (78) 497 (77) 84 (78) 76 (83) 0.43 
      > 6 months (Later) 188 (22) 150 (23) 23 (22) 15 (17)  
a Values are mean ± SD unless otherwise stated. 
b t-tests and chi-square tests were run to assess difference in means or % between non-GDM and GDM groups.  
Significant p-values (<0.05) are bolded. 
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Logistic Regression Analyses 
Results from the multinomial logistic regression are shown in Table 15. Variables 
such as child age and sex that did not vary among all three BMI categories were not 
included in the model. Thirteen percent (n=107) of children were overweight (≥95th BMI 
percentile) and 11% (n=91) had obesity (≥95th BM percentile). Compared to normal weight 
children, children with overweight or obesity had higher odds of being born LGA 
(OR=1.61, 95%CI 1.03-1.19, p=0.04; OR=3.46, 95%CI 2.24-5.26, p<0.0001). Hispanics 
were 59% and 68% more likely to have overweight and obesity compared to NHW children 
(both p<0.05). BF duration and intensity scores were inversely associated with obesity 
prevalence in children 2-5 years of age (all p<0.01). Compared to normal weight offspring 
who were breastfed for at least six months, children who were breastfed for shorter than 
six months had significantly higher odds of obesity (OR=2.33, 95%CI 1.48-3.67, 
p=0.0008). However, there were no significant differences between the BF groups in 
children with overweight compared to normal weight offspring. Greater breastfeeding 
intensity and duration (12-month combined) score was linked to lower odds of overweight 
and obesity, independent of covariates (p=0.009, p=0.003). Children who had obesity and 
overweight had 3.46- and 1.6-times higher odds of being born LGA than normal weight 
children (OR=3.46, 95%CI 2.24-5.26, p<0.0001; OR=1.61, 95%CI 1.03-2.54, p=0.04).  
There was an overall significant association between beverage intake and BMI 
percentiles in the model (p=0.03). Both SSBs and unsweetened 100% juice intakes were 
independently associated with higher odds of obesity in children (OR=3.00, 95%CI 1.48-
6.00, p=0.002 and OR=2.24, 95%CI 1.23-4.10; p=0.008). However, these associations 
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were attenuated to trends for offspring with BMI- for-age ≥85th to 95th percentiles. There 
was an overall significant relationship between the stratified beverage and BF intake and 
odds of overweight and obesity in the model (p=0.03). Compared to normal weight children 
who were breastfed for at least six months and had no SSBs intake (referent), offspring 
who were BF and had unsweetened 100% juice and SSBs intake had three and four folds  
higher odds of obesity (OR=3.19, 95%CI 1.07-9.53, p=0.03; OR=3.67, p=0.02 and 95%CI 
1.18-11.45, p=0.02). Compared to the referent group, children who were BF<6months or 
not BF and had no SSBs or 100% juice intake had three times higher odds of obesity 
(OR=2.85, 95% CI 1.11-7.29, p=0.03). Compared to normal weight children who were 
breastfed with no SSBs or 100% juice intake, those who were not breastfed or were 
breastfed for shorter than six months with any SSBs and 100% juice intake were five and 
eight times more likely to have obesity (OR=4.63, 95%CI 1.82-11.80, p=0.001; OR=7.53, 
95%CI 2.68-21.10, p<0.0001). Figure 5 displays the odds of obesity by BF-Beverage 




Figure 5. Obesity prevalence among 2-5 years old children by BF-SSBs groups 
*Significantly lower odds compared to referent 
BF-GDM-SSBs and Obesity and Metabolic Disease Prevalence  
 
102 
Table 15. Logistic multinomial regression of prenatal and early postnatal influences on the subsequent prevalence of obesity in 
children aged 2 to 5 years exposed to GDM in utero 
    Child BMI Categories at Ages 2 to 5 Years 
Variables    Overweight (85th to <95th%tile)  Obesity (≥95th%tile) 
  Overall P  Pa  ORb (95% CI)  Pa  ORb (95% CI) 
Breastfeeding Duration (BF) categories  0.001         
BF (≥6 months)    Referent  1.00  -----  1.00 
Short BF (<6 months)    0.69  1.09 (0.72,1.66)  0.0008  2.33 (1.48, 3.67) 
Breastfeeding Intensity and Duration Score Sum 
of 12 Monthly Ratios (Birth to 12 months of age) 
          
      Score ≥ 6  0.0005  Referent  1.00  -----  1.00 
      Score < 6    0.32  1.38 (0.91, 2.10)  0.0004  2.45 (1.50, 4.10) 
      Score ≥ 9  0.007  Referent  1.00  -----  1.00 
      Score < 9    0.007  1.89 (1.18, 3.02)  0.002  2.35 (1.36, 4.07) 
Beverage Feeding (Birth to 1 year)  0.03         
No SSB/Juice    Referent  1.00  -----  1.00 
SSB Ever    0.33  1.36 (0.72, 2.52)  0.002  3.00 (1.48, 6.00) 
100% Fruit Juice Only    0.36  1.24 (0.77, 2.00)  0.008  2.24 (1.23, 4.10) 
Covariate Adjusted SSBs Groups Stratified by BF Status 
Race/Ethnicity, n (%)  0.02         
None-Hispanics    Referent  1.00  -----  1.00 
     Hispanics    0.04  1.59 (1.03, 2.45)   0.03   1.68 (1.05, 2.67)  
Prenatal 3-hr 100 g OGTT sum of z-scores  0.006  0.41  0.96 (1.03, 1.19)  0.02  1.11 (1.01, 1.17) 
Size-for-Gestational Age   <0.0001  0.03       
      Appropriate (AGA)/ Small (SGA)    Referent  1.00  -----  1.00 
      Large (LGA)     0.04  1.61 (1.03, 2.54)  <0.0001  3.46 (2.24, 5.26) 
Maternal Gestational Weight Gain (kg)  0.80  0.55  0.99 (0.96, 1.02)  0.14  0.97 (0.94, 1.01) 
Gestational age at GDM diagnosis (weeks)   0.006  0.66  1.01 (0.97-1.04)  0.003  0.95 (0.93, 0.98) 
BF-SSB Groups (Intake Ever Birth to 1 year)  0.03         
BF, No SSB/Juice    Referent  1.00  -----  1.00 
BF, Pure Juice    0.57  1.26 (0.57, 2.77)  0.03  2.85 (1.11,7.29) 
BF, SSB Ever     0.40  1.43 (0.62, 3.26)  0.02  3.67 (1.18, 11.45) 
Short BF, No SSB/Juice     0.39  1.29 (0.71, 2.35)  0.03  3.19 (1.07, 9.53) 
Short BF, Pure Juice    0.47  1.26 (0.66, 2.43)  0.001  4.63 (1.82, 11.80) 
Short BF, SSB Ever    0.44  1.37 (0.58, 3.26)  <0.0001  7.53 (2.68, 21.10) 
aSignificant P-values (<0.05) are bolded; bOR: Odds Ratio; The following covariates were used in the regression model: Child sex/ethnicity, prenatal 3-hr 100 g OGTT sum of z-scores, size-for-gestational 
age, and gestational age at GDM diagnosis. 
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DISCUSSION 
This prospective study of infants of mothers with GDM is the first prospective study 
to show SSB and 100% fruit juice intakes during the first year of life were independently 
associated with increased obesity risk at 2-5 years of age whereas higher BF duration (≥ 
6months) and intensity (score>9) were independently associated with decreased risk of 
obesity in GDM offspring. Our findings show that low BF duration and intensity score and 
high SSBs and 100% fruit juice intake in infancy were associated with a 2.2-fold to 2.5-
fold increased odds of future obesity at 2 to 5 years of age in children exposed to GDM in 
utero. This finding was consistent with those of the SWIFT Offspring Investigators.137 A 
previous analysis of 382 SWIFT children (2-5 years of age) by the SWIFT Offspring 
Investigators showed that higher BF intensity and duration were associated with lower 
odds of obesity in GDM offspring. Although many studies including the current study have 
reported an inverse association between exclusive BF (EBF) and body mass index (BMI) 
and excessive weight gain later in life 256, the evidence for the association of BF and SSBs 
intake with slower infant growth is sparse and majority of the studies that have assessed 
such association are retrospective and rely on recall of BF duration. The only prospective 
study that has found a protective association is the SWIFT offspring study by Gunderson 
et al. They showed in the SWIFT cohort that greater BF intensity and duration were 
associated with slower ponderal growth and less weight gain from birth to one year among 
infants of mothers with GDM.136  
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Our main finding was that compared to children who were breastfed for at least six 
months and had no SSBs or 100% fruit juice intake (referent) during the first year of life, 
offspring who were breastfed for at least six months and consumed 100% fruit juice and 
SSBs in infancy had 2.9 and 3.7 times higher odds of obesity at 2-5 years of age. Odds 
ratios were about 1.5 times higher for those who were breastfed for shorter than six months. 
Findings of the current study were consistent with a recent cross-sectional study of 3,707 
mothers and their children (1-5 years of age) participating in WIC clinics in Los Angeles, 
CA in regard to association of BF duration and SSBs intake with obesity prevalence. The 
above study assessed the association of EBF during the first year of  life and SSBs intake 
at age 1-5 years with obesity prevalence in offspring born to mothers with and without 
GDM and showed that offspring who were BF exclusively for at least six months and had 
no current SSBs intake had lower odds of high-weight- for-length (1-<2 years of age) and 
obesity (2-5 years of age) than those EBF≥6 months with high SSBs intake (i.e.; >3 
servings per day) regardless of GDM status of their mothers throughout pregnancy.240 Of 
note, the above study was a cross-sectional study that assessed the mentioned association 
with obesity status in much younger children born to healthy (n=3,237) and GDM (n=470) 
mothers and did not account for SSBs during the first year of life nor did they control for 
GDM severity, gestational weight gain, gestational age at GDM diagnosis, and infant size 
at birth. Also, the BF intensity score and 100% fruit juice intake during the first year of life 
were not included in the mentioned study. Strengths of the current SWIFT study include 
the meticulous methods of diet assessment of GDM offspring during the first year of life, 
including quantitative methods of BF intensity measurement249, the very well-
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characterized fetal life exposure, large sample size, racial/ethnic diversity of participants, 
prospective design and longitudinal follow up of outcomes, and comprehensive covariates 
including GDM severity, gestational weight gain, infant size at birth, gestational age at 
GDM diagnosis, and prenatal 3-hr 100 g OGTT sum of z-scores.137 
While research shows that BF is linked to lower obesity prevalence in offspring, 
only a few studies have shown the impact of BF in offspring exposed to GDM7,136,240 and 
the mechanism behind this association has not been well studied. Human milk 
oligosaccharide (HMOs) serve as a fuel for microbiota in human milk and therefore 
breastfed infants develop healthier gut microbiome than formula fed children because of 
consumption of  human milk microbiota, which is linked to reduced obesity risk in 
children.237 It is still unknown whether human milk constituents such as HMOs, leptin, 
insulin, and other hormones and nutrients in milk of mothers particularly those with GDM  
play a role in reducing obesity rates in offspring and more research is warranted. 
The current study is the first prospective study to examine the association between 
100% fruit juice intake during the first year of life and obesity status in GDM exposed 
children (2-5 years of age). Children who were BF for at least six months and had 100% 
fruit juice intake during the first year of life had about three times higher odds of obesity 
than those with no intake of SSBs 100% fruit juice. Research on the 100% fruit juice intake 
during the first year of life with future obesity prevalence is sparse and the current findings 
on early exposure to 100% fruit juice and obesity are inconclusive257-259 with some studies 
linking 100% fruit juice to increased BMI z score at age 1-6 years 248, while other studies 
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found no association between 100% fruit juice intake and obesity in children.260 A meta-
analysis of 4,657 articles reported that eight prospective cohort studies with  34, 470 
children (1-18 years of age) found an associations between 100% fruit juice (6-8 oz./day) 
consumption and BMI z score controlling for total energy intake only in children ages 1 to 
6 years. However, the mentioned association was not clinically significant.248 In contrast, 
a systematic review of the literature that were published during 1995-2013 reported that 
majority of the studies did not find a significant association between 100% fruit juice intake 
and weight and adiposity in children. 260 However, the above studies did not examine the 
independent and additive associations of BF duration and intensity scores with SSBs and 
100% fruit juice intake during the first year of life on obesity status. Nor did the above 
studies target an exclusive GDM population, while controlling for GDM severity, 
gestational weight gain,  and gestational age at GDM diagnosis.  
There are a few limitations of the current study to consider. The current study did 
not include observational or physiological measures of breastfeeding. Residual 
confounding associated with measurement error for beverage and dietary intake covariates 
may have affected results. Also the current study was conducted in California101, which is 
a state with higher BF rates than other areas in the United States. Another limitation is that 
pre-pregnancy maternal BMI was self-reported, and evidence shows that Hispanic adults 
underreport overweight/obesity prevalence by 4.1-5.1%261. However, this study did not use 
self-reported anthropometrics, and heights and weights of children were measured by 
trained staff.  
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In conclusion, findings of this study highlight the need for interventions targeting 
women with GDM to focus on promoting higher BF duration and intensity and lower SSBs 
and 100% fruit juice in diet of their children during the first years of life. In conclusion, 
this study suggests that the combination of BF and no SSBs and 100% fruit juice intake 


























Chapter 5: Conclusions and Public Health Implications 
 
This research is one of the first to examine the independent and interaction effects 
of Gestational Diabetes Mellitus (GDM), Breastfeeding (BF), both exclusive and any BF, 
duration and intensity, and SSBs and 100% fruit juice intake on weight gain, obesity, 
prediabetes, and MetS prevalence in children from birth to 19 years of age who were born 
to mothers with GDM versus non-GDM population. Specifically, this dissertation 
examined: 1) the independent and interaction effects of GDM and BF duration (≥1month 
vs <1month) on the prevalence of prediabetes and MetS in Hispanic children (8 to 19 years 
of age) born to mothers with and without GDM; 2) the independent and interaction effects 
of GDM, exclusive BF duration (≥6 months vs. <6months), and SSBs intake (i.e.; low SSB 
(≤1 serving/day), medium SSB (>1 and ≤3 servings/day), and high SSB (>3 servings/day)) 
with offspring’s high weight-for-length BMI percentile rate at 12 months through two years 
of age and overweight and obesity prevalence among at 2-5 years of age; and 3) the 
prospective relationship between early life infant feeding (BF duration (≥6 months vs. 
<6months) and intensity score (≥9 vs. <9), and introduction to SSBs (Any SSBs/juice vs. 
100% fruit Juice vs. No SSBs/juice) on overweight and obesity prevalence among GDM 
offspring at 2-5 years of age.  
The first analysis from the SOLAR cohort (Chapter 2) found that BF for at least 
one month was associated with lower odds of ever and persistent MetS and prediabetes in 
both GDM and non-GDM offspring. Only a few studies have shown an independent 
association between GDM and abnormal glucose tolerance and cardio metabolic risk75,77,262 
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in children and the current study was the first to assess the association between BF and 
GDM status on the prevalence of the Metabolic Syndrome (MetS) and prediabetes in young 
children (8-19 years),  particularly in a high-risk Hispanic population. Finding from this 
study fill a gap in the literature by assessing the mentioned association in offspring exposed 
to GDM in utero. Of note, the majority of studies that assessed the mentioned association, 
including the current study, were not collected in a longitudinal and prospective setting, 
had small sample sizes in homogenous populations, did not control for GDM severity and 
other maternal and prenatal factors affecting prediabetes and MetS risk in offspring. In 
addition, most of the studies collected self-reported data in a retrospective design. 
Therefore, further large-scale prospective longitudinal interventions are warranted to draw 
a firm conclusion.  
The second analysis (chapter 3) showed that GDM and high SSBs intake were 
independently associated with higher odds of high weight for length in offspring 1-<2 years 
of age and obesity at 2-5 years of age, whereas, EBF for at least six months was linked to 
lower odds of high weight for length in offspring ≤12 months to <2 years of age and obesity 
at 2-5 years of age. Findings of this study were consistent with previous studies.263 Of note, 
the previous and current studies were not longitudinal prospective cohorts, did not account 
for SSBs during the first year of life nor did they control for GDM severity, gestational 
weight gain, gestational age at GDM diagnosis. Our third analysis (chapter 4) findings were 
consistent with our previous findings, showing that higher BF duration (≥6months) and 
intensity score (≥9) were associated with decreased odds of future obesity whereas SSBs 
and 100% fruit juice intake during the first year of life, were independently associated with 
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higher obesity risk at 2-5 years of age in children exposed to GDM in utero. Our third study 
is one of the first prospective studies that assessed the mentioned association in an 
exclusive GDM population accounting for GDM severity, maternal age at GDM diagnosis, 
and gestational weight gain. However, our third analysis was not a longitudinal research 
and did not have a non-GDM control group. 
There is debate and question about whether breast milk of mothers with GDM and 
early exposure to SSBs and 100% fruit juice affect health outcomes in offspring. Findings 
of this dissertation help clarify the answer to this question and support the current 
recommendations regarding the beneficial effects of breast milk and its components on 
health of children compared to other foods including formula, SSBs, Juice, and solid foods 
in GDM offspring. Although several studies including the current research findings 
indicate that BF regardless of GDM status of mothers reduce risk of many health 
complications in mothers and their children7,136,162,240,264, there are many factors that may 
impact a mother’s decision in regard to BF. Difficulties of BF may be higher for women 
with GDM because of delayed onset of lactogenesis and medical management of mothers 
and their newborns.60 One of the main barriers of BF is lack of knowledge about protective 
impact of BF on health of children. Unfortunately, many women in the U.S. are uncertain 
about what to expect with BF and are not aware of  BF techniques. Although there are 
several BF campaigns and programs that encourage women to breastfeed, majority of them 
only provide written educational materials as their source of information.265 It is important 
to conduct more effective programs that provide more effective BF education and 
involvement to influence their attitudes about BF.  
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Numerous interventions have been conducted globally to increase BF rate and 
duration, provide practical, psychological, and direct supports to mothers on how to 
breastfeed and overcome BF barriers. There are numerous types of interventions to 
promote exclusive BF rates including educational, home and family support, in-person 
group classes, professional and  peer support, one-on-one counseling, telephone, 
electronic, and web-based counseling and education, and community interventions. There 
are also BF tracker applications that mothers can download and use, which help mothers 
to keep track of BF and learn more about BF. All types of interventions may be delivered 
before, during, and after pregnancy. There is strong evidence that BF promotion 
interventions have been successful in increasing BF initiation, duration, and exclusivity. A 
meta-analysis of 7,201 randomized controlled trials (RCTs) showed that educational 
interventions on BF that were thoroughly explained to women, were more effective than 
routine guidance from the health service on BF.266 An intervention study conducted in 
Australia examined the effectiveness of an internet-based EBF rate promotion, reported 
that internet-based intervention programs were successful at increasing EBF rate in women 
who had hard time BF their child.267 A quasi-experimental study examined the 
effectiveness of a family-centered BF education program on encouraging EBF up to six 
months and improving attitude and knowledge of women’s and their families reported that 
the intervention group was more likely to EBF, had higher family support, and had 
improved knowledge level of bf than the control group.268 A systematic review of 23,977 
suggested a concurrent involvement of interventions including health systems, home and 
family, and the community environment to improve BF rate, duration, and continuation.269 
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A systematic review and meta-analysis of 27 RCTs including 36,051 mothers suggested 
that considering a multicomponent intervention improves effectiveness of the BF 
promotion programs.270 Although research shows that BF interventions have been 
successful in promoting EBF initiation, duration, and continuation rates in women, none 
of them have targeted the high-risk pregnant groups including women with GDM and other 
complications during pregnancy who experience more difficulties BF60 and may need more 
support to breastfeed their child. Considering barriers of BF and our findings in regard to 
the important role BF plays in lowering the risk of childhood obesity and other metabolic 
disease in offspring of women who had GDM during pregnancy, there is a need for 
interventions promoting EBF in high-risk groups GDM women are warranted. 
When conducting interventions with GDM mothers, it is important to recruit 
mothers before or at their GDM diagnosis to help control their GDM by providing 
education and guidance on healthy diet and BF to control their GDM and prepare them for 
a successful BF experience.  Barriers to consider with interventions to promote BF are 
social norms and employment of mothers. Mother’s employment is one of the leading 
barriers for early weaning and stopping BF. It is recommended that organizations and 
workplaces to provide maternity leave and increase the number of on-site rooms for BF. 
Additionally, countries adopting legislation reflecting the provisions of the International 
Code of Marketing of Breast-milk Substitutes (WHO Code), which is 
“an international health policy framework for BF promotion”, have higher BF rates. Of 
note,  U.S. was one of the two countries that refused to implement the provisions of the 
code and enact legislation.271 A legal action is needed to overcome these barriers and 
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improve BF rate nationwide. Health care professionals including obstetrician-
gynecologists, registered dietitians, nurses, pediatricians, and other providers of maternal 
and child care also play an important role with regard to promoting and supporting 
women’s decisions about BF.  
The current dissertation found that offspring who had high SSBs intake and 100% 
fruit juice had higher odds of obesity. Toddlers and young children have the highest fruit 
juice intake among all age groups in U.S. and most U.S. children exceed 
the recommended limits for added sugars in the diet and a large portion of their daily 
calorie comes from SSBs and 100% fruit juice. 246 Higher weight gain and BMI z score in 
SSBs consumers is mainly due to increased total calorie intake from high sugar content, 
mainly fructose, in SSBs.239,272-274 Also, research shows that SSBs and high sugar snacks 
are less satiating than intake of protein or fat, therefore, children who have high intake of 
SSBs feel hungrier and consequently have higher total calorie intake than children who do 
not drink SSBs.275 Increased SSBs consumption among U.S. children has become a 
concern and there are controversies on banning of the sale of large-volume servings of 
SSBs. A few U.S. cities have started adding taxes, up to two cents per ounce, on SSBs in 
order to lower consumer demand for SSBs and help improve purchasing healthier food.276 
Although drinking 100% juice is recommended as a healthy beverage option, there 
has been a lot of controversy about intake of 100% fruit juice and obesity in children.248,257-
259 Our findings did not support this recommendation and instead we agree with Wojcicki 
et al.’s recommendation on that the U.S. Department of Agriculture’s Child and Adult Food 
Care Program to promote the elimination of 100% fruit juice to reduce the prevalence of 
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childhood obesity.259 We support the American Academy of Pediatrics’ recommendation 
in regard to not introducing any SSBs or 100% juice to diet of infants younger than one 
year of age, maximum of 4 ounces  per day 100% juice products for 1-3 years old children, 
and 4-6 ounces for children ages 4-6 years.277 Considering the adverse health outcomes of 
SSBs and how rates of SSBs intake among young children are increasing, there is a need 
for interventions that target reducing SSBs consumption. Numerous interventions 
including educational and behavioral interventions (campaigns, workshops, and 
advertising), price increase and taxation on SSBs, limiting the availability of SSBs at 
schools, restaurants, and stores, promoting healthy beverages and water intake, labeling 
and added sugar reduction, and policy and environmental changes have been some of the 
principal strategies targeting SSBs intake reduction.278,279  
Although there are several proposed interventions to decrease SSBs consumption, 
strength and availability of evidence supporting these interventions varies. A systematic 
review and meta-analysis of 12 school-based and four community- and home-based 
interventions found a moderate effectiveness of educational and behavioral interventions 
on reducing SSB intake among children aged 4 to 16 years.280 Another systematic review 
and meta-analysis of 90 RCTs reported that public health interventions particularly 
nutritional education/counseling interventions were moderately effective at decreasing 
SSBs and increasing water intakes in children. In addition, behavioral interventions within 
the home environment had greater effects on decreasing SSBs intake in children than 
school-based interventions.281 A couple of systematic review studies found little evidence 
that water promotion interventions reduce SSB intake.281,282  Of note, there is no strong 
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evidence on effectiveness of SSB intake reduction strategies in young children, 
highlighting the need to conduct interventions targeting SSB reduction in mothers of young 
(birth-2 y) children. 
In summary, higher breastfeeding intensity and duration and lower SSBs decreases 
childhood obesity, diabetes, and metabolic syndrome in offspring exposed to GDM. 
Findings of this research highlight the need to encourage mothers diagnosed with 
gestational diabetes during pregnancy to breastfeed their children for at least six months or 
longer and to not expose their toddlers to sugar sweetened beverages intake. These are two 
highly modifiable infant and child feeding approaches that can have profound effects on 









Chapter 6: Future Plans and Avenues of Research 
Starting in the Fall of 2019, I will begin a postdoctoral position in Nutrition. I am 
the process of interviewing for several postdoctoral fellows at various accredited 
universities and hope to accept an offer in the next month. As a postdoctoral fellow, I am 
interested in conducting research on current nutrition issues, especially maternal, prenatal, 
and early life nutrition, as well as familiarizing myself with other related research areas. I 
am interested in expanding my exploration into how different factors like dietary intake, 
environmental, and public health factors impact obesity and other related complications 
across all age groups. I am also interested in examining how dietary related behaviors 
impact obesity, diabetes, and related metabolic diseases risk in youth. I would also like to 
obtain more training and knowledge on how to conduct controlled feeding trials. My goal 
is to expand my research, analytical, and grant writing skills, which will help me achieve 
my goals of becoming a tenure-track faculty member in Nutrition or related field at 
a research-intensive university. I wish to work in academia where I would have the 
opportunity to teach nutritional courses, provide mentorship to my own research team, and 
mentor students. 
During my doctoral studies, I have gained some experience in writing grants and 
have been awarded two small pilot grants. The first grant titled “Austin School Gardens: 
Assessing the landscape of gardening schools around Austin” was funded by the City of 
Austin, Office of Sustainability and the second pilot grant was funded by the Academy of 
Nutrition and Dietetics “Pilot Study: Behavioral, Environmental, and Policy Factors 
Influencing Childhood Obesity”. The pilot grant from the Academy of Nutrition and 
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Dietetics was to collect data from WIC clinics across the Austin area and examine the 
association of behavioral, environmental, and policy factors with childhood obesity among 
Hispanic youth. I am the process of data analyses for this study and will prepare a 
manuscript reporting these findings during Fall 2019. 
In addition, I have gained ample project management experience. For the garden-
based pilot study listed above, I developed the surveys, trained UT undergraduate students 
in data collection procedures, and supervised all data collection.  The results of this study 
will be published in a manuscript as well as part of a City of Austin report, that will then 
be used to inform city policy. I have also served as a wet lab manager on a large NIH 
funded trial (PI: Davis), which involved creating protocols for blood processing, and 
supervising and training many students and staff on these procedures, overseeing lab 
safety, and assisting with anthropometric measurements. Beyond these project 
management experiences, I have mentored an Honors in Advanced Nutritional Sciences 
undergraduate student on her thesis project, which included training the student in data 
analysis, manuscript preparation, and thesis writing. I am currently working on a 
manuscript using baseline data from over 3,000 Hispanic youth (7-11 years of age) to 
examine the effects of cooking and gardening attitudes and self-efficacy on dietary intake 
using NDS-R 24-hour diet recalls. By the time I graduate, I will have up to four first author 
publications, ten co-authored publications, along with advanced analytical skills, expertise 
using NDS-R software, and experience analyzing large nutritional datasets.  
All of my above experiences and trainings has shaped my research interests and I 
would love to expand my background in maternal, prenatal, and childhood nutrition by 
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evaluating how several factors including dietary factors (i.e. micro- and macronutrients 
intake), sociodemographic (i.e. age, sex, language and immigration), socioeconomic status 
(i.e., food insecurity, income, and education), epigenetic (gut and vaginal microbiome), 
mode of delivery, and exposure to environmental pollutants and toxicants like bisphenol A 
can impact health outcome in mothers and their children. I would like to pursue further 
research on the role that family members specially fathers can play to support and 
encourage their wives/partners to breastfeed their child. Moreover, there is a need to further 
investigate the compositions of breast milk (i.e. HMOs, leptin, and insulin levels) specially 
milk of mothers with GDM and their influence on health outcomes in children. 
Additionally, considering the increased intake of SSBs specially among children and 
adolescence, I would like to design an intervention that helps decreases rate of SSBs intake 
and promotes healthy beverages such as water and aqua frescas consumption across all age 
groups. I would also like to study more about the effectiveness of taxation on SSBs and 
how researchers and health care professionals can collaborate with the state legislatures 
and politicians to eliminate availability of SSBs at daycares and schools and eventually 
help promote drinking healthy beverages instead.  
My goal is to pursue a postdoctoral position that would expand my current 
experience in maternal, prenatal, and early life nutrition while additionally obtaining skills 
in areas such as public health nutrition and epidemiology, longitudinal study design and 
dietary feeding trials, use of the National Health and Nutrition Examination Survey 
(NHANES) and the National Collaborative on Childhood Obesity Research (NCCOR). 
Ultimately, I would like to join a multidisciplinary research team and collaborate with 
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pediatricians, obstetrics and gynecology physicians, dietitians, nurses, psychiatrists, 
psychologists, and epidemiologists to work on projects that combine more expertise and 
disciplines in this field and lead to creative and high impact research. By working with a 
multidisciplinary research team, I would be able identify different barriers of BF promotion 
and SSBs intake reduction and consequently design an effective intervention that applies 
dietary, physiological, epidemiological, and psychological aspects of BF, SSBs intake, and 
health outcomes in children and adults. By incorporating my knowledge of nutrition and 
epidemiology and future collaborations with other health care professionals , hopefully I 
will be able to lead my own research team as a tenure-track professor at a prestigious 
university and help our society to understand how dietary choices and other factors can 
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